Skip to main content
Journal of Clinical Medicine logoLink to Journal of Clinical Medicine
. 2026 Mar 14;15(6):2212. doi: 10.3390/jcm15062212

Characterizing Initial Cervical Spine and Neurovascular Findings in 84 Consecutive Patients with Hypermobile Ehlers–Danlos Syndrome: A Retrospective Study

Ross A Hauser 1, Morgan Griffiths 2, Ashley Watterson 3, Danielle Matias 1, Benjamin R Rawlings 1,*
Editor: Moshe Salai
PMCID: PMC13026537  PMID: 41899137

Abstract

Background: Hypermobile Ehlers–Danlos syndrome (hEDS) can present as a complex interplay of widespread symptomatology and multisystem involvement, posing diagnostic and treatment challenges. Objective characterization of cervical spine and neurovascular findings in hEDS has been limited. Previous studies have emphasized upper cervical spine complications in hEDS, yet the relevance and mechanisms underlying associated symptomatology have not been elucidated. This study examined objective test findings in patients with hEDS at an outpatient neck clinic to explore cervical spine and neurovascular pathology that could contribute to further understanding the clinical profile of a subset of patients with hEDS. Methods: This single-center, retrospective observational study included patients with hEDS aged 20–50 years from 1 January 2022–31 December 2024, at an outpatient neck center. It excluded previous neck surgery, traumatic events, or related injury. Demographic, clinical, and diagnostic data were collected through a retrospective chart review, including measurements from standard clinical diagnostic protocols: digital motion X-ray (videofluoroscopy), cone beam CT, Doppler ultrasound, and tonometry. Results: More than 71% of patients reported ≥29 symptoms. Nearly all patients exhibited co-occurring forward head, decreased depth of curve, ligamentous cervical instability, and decreased internal jugular vein (IJV) and vagus nerve cross-sectional area (CSA). Vagus nerve CSA was found to be significantly smaller than the comparative healthy/normal population. IJV CSA was significantly smaller at C1 than at C4–C5, suggesting evidence of carotid sheath compression at C1. Conclusions: This study offers novel evidence that cervical spine pathology, IJV compression, and vagus nerve degeneration are uniformly prevalent in hEDS, which may contribute to, or be an etiological basis for, the multisystem involvement in a subset of patients with this disorder. These findings provide hypothesis-generating data to inform future mechanistic and therapeutic studies, including exploration of new diagnostic and treatment targets.

Keywords: hypermobile Ehlers–Danlos syndrome, cervical instability, cervical lordosis, forward head, internal jugular vein, vagus nerve, autonomic nervous system

1. Introduction

Ehlers–Danlos syndromes (EDSs) are clinically defined as a genetically heterogeneous group of connective tissue disorders, including 13 variants with 21 distinct gene mutations, defined by the 2017 International Classification, and primarily affecting collagen structure [1]. EDS is currently estimated to present in 1 in 500 people based on a recent study involving Welsh healthcare records, which is far greater than the previously thought-to-be-rare estimated occurrence of 1 in 5000 (0.2% vs. 0.002%), though the condition may still be underrepresented due to variability in diagnostic criteria combined with the presence of overlapping conditions [2,3,4]. Hypermobile EDS (hEDS) is characterized by generalized joint hypermobility, musculoskeletal pain, ligamentous joint instability, and a plethora of systemic manifestations often affecting quality of life, the most recognizable clinical signs including musculoskeletal pain, joint hypermobility, skin hyperextensibility, and tissue fragility [5,6]. Hypermobile Ehlers–Danlos syndrome accounts for more than 90% of all EDS cases, with females accounting for 70–90% of hEDS, and as of yet, no definitive genetic mutation has been found, and the cause for the widespread symptomatology is poorly understood [7,8].

Patients with hEDS were selected for this study because their generalized connective tissue laxity, a defining feature of the disorder, may predispose them to cervical spine instability. Previous studies have emphasized upper cervical spine problems in hEDS, ligamentous cervical instability being a frequently considered and potentially disabling complication, yet it has not been consistently examined as a potential structural framework contributing to the broader symptom profile in this population [9,10]. Exploring neurovascular and autonomic dysfunction potentially associated with cervical spine instability in patients with hEDS could lead to characterization of modifiable pathophysiological mechanisms. This characterization could provide a framework for more targeted and mechanistic interventions beyond symptom management and guide individualized therapeutic approaches.

Hypermobile Ehlers–Danlos syndrome patients often experience a wide range of chronic and disabling symptoms, including not only musculoskeletal complaints, but also cardiovascular, neurological, gastrointestinal, and autonomic dysfunctions at a higher rate than the general population, all categories which were highly prevalent in this study [11] (Figure 1). Determining exact frequencies within the general population is inherently difficult for categories of this breadth; however, many investigations have examined them through small-scale comparisons [12,13,14,15]. The exact etiology of the myriad symptoms that patients with hEDS suffer from continues to be a conundrum.

Figure 1.

Figure 1

The percentage of musculoskeletal, cardiovascular, neurological, psychological, and gastrointestinal complaints in this cohort of hEDS patients. Figure copyright belongs to authors.

Chronic pain is often the most prevalent symptom, though there are currently no established treatment guidelines for managing or resolving the pain in hEDS patients [16]. Up to 56% of patients with hEDS receive a misdiagnosis, and the complexity of the condition often results in a delayed diagnosis of up to 28 years [17]. Studies have also found that symptom severity progresses over time, and progression is heterogeneous, multisystemic, and unpredictable, even in children [18,19,20]. In a recent cross-sectional, anonymous online survey involving patients with hEDS, participants reported 24 comorbid diagnoses on average, with diagnostic delays averaging over 20 years [3]. Chronic pain was most frequently the most severe symptom, with neck pain being the most frequent site [3].

The chronic disabling and often progressive symptoms of hEDS coupled with treatment uncertainties cause psychological distress and tremendous adverse mental health effects, in addition to the physical symptoms [21,22]. The variability in the range and severity of symptoms, and a lack of uniformity in the etiology of these symptoms, makes treatment plans difficult and often suboptimal, which emphasizes the relevance of investigating potentially treatable underlying mechanisms [23]. Despite emerging evidence of dysautonomia, altered cerebrovascular control, and neuropathic features present in hEDS, multisystem abnormalities have rarely been considered together in a unified framework that could explain the widespread symptom patterns, making it difficult to infer integrated mechanisms that could link neuromuscular and autonomic manifestations of this condition [24,25]. Consequentially, there is limited high-quality evidence of treatment approaches for the widespread severely disabling symptoms, and current management remains symptom-based rather than being guided by pathophysiological pathways [8,26,27].

The aim of this study was to further understand the clinical profile of patients with hEDS at an outpatient neck center by exploring potential cervical spine pathology, including ligamentous cervical instability, and identifying pathophysiological patterns prevalent in the cohort which could elucidate mechanisms to potentially help explain the widespread symptomology and multi-system involvement in this condition. Current hEDS treatment is aimed at pain and symptom management and improving quality of life, focused on pharmaceuticals, lifestyle modifications, bracing, physical therapy, education, and psychological intervention, often involving multiple different teams of specialists, all of which pose significant diagnostic and treatment challenges [28]. To our knowledge, systematic evaluation of cervical spine instability and adjacent neurovascular findings in patients with hEDS has not been studied. This study adds to the current literature by identifying consistent cervical spine and neurovascular findings in a cohort of patients, providing preliminary data that may inform future investigations into potential structural and autonomic contributors to symptom burden in hEDS, and possibly leading to new diagnostic and treatment targets.

2. Methods

2.1. Study Population

In this retrospective, descriptive, observational study, 84 consecutive patients with hEDS were identified from a clinical database review of patients reporting to The Hauser Neck Center (an outpatient neck clinic in Fort Myers, Florida, USA) from 1 January 2022–31 December 2024. The clinic has an international referral base, and patients come primarily to see if they have a structural neck issue, specifically ligamentous cervical spine etiology, as a potential cause or contributor to their varied disabling symptoms. All patients aged 20–50 with an hEDS diagnosis who met the 2017 International Classification criteria were included. We excluded patients who had a history of neck surgery, traumatic events, or related injuries. The 84 patients included represent all consecutive individuals meeting eligibility criteria during the study period. They were not preselected based on imaging findings or symptom severity. Clinical care was delivered according to standard protocols, and the retrospective analysis was conducted subsequently. This study was designed as a descriptive, cross-sectional characterization of initial clinical test findings. No additional subgroup analyses were performed.

The patient group was 15% male and 85% female. Informed consent was obtained from the subjects after an explanation of the nature and possible consequences, and the study was approved by the WIRB-Copernicus Group (WCG) Institutional Review Board (Study #20252006) (Figure 2).

Figure 2.

Figure 2

Patient inclusion flow chart. Figure copyright belongs to authors.

Demographics, symptoms, and clinical test results were collected by chart review, including age, gender, upright digital motion X-ray (DMX, videofluoroscopy), and upright cone beam CT (CBCT) of the cervical spine, pupillometry, tonometry, and ultrasound of the carotid sheath (internal jugular veins and vagus nerves) and the eye (optic nerve) (Figure 3). All diagnostic procedures were performed by a radiology technologist or medical ultrasonographer for clinical (not research) purposes. All in-clinic imaging and testing were performed following standardized clinical protocol, minimizing potential bias. Formal research blinding was not implemented due to the retrospective study design. Selection bias is inherent to this retrospective single-center study design, potentially limiting the generalization of the findings, although it allows for detailed characterization of patients with hEDS seeking care at a self-referred neck clinic.

Figure 3.

Figure 3

Neck vitals analysis. (A) Tonometry. (B) Pupillary light reflex. (C) Optic nerve sheath diameter. (D) Internal jugular vein (IJV) cross-sectional area (CSA) at C4–C5. (E) IJV CSA at C1. (F) Vagus nerve CSA. Figure copyright belongs to authors. (Reproduced from Ref. [29]).

This study included only symptom frequencies and data collected at initial intake. Symptoms were included in the analysis if >70% of patients reported them, resulting in 29/81 symptoms included. Follow-up data were not included. Symptoms documented at initial intake are reported as frequencies, with the number and percentage of participants experiencing each. The objective test results (quantitative variables) were analyzed as continuous variables. Descriptive statistics included means and standard deviations. No confounding variables were identified or adjusted for in this analysis, which already excluded previous injuries and traumatic events. This study did not include an analysis of effect modifiers, though modifications such as head position and movement may be considered in future investigations. This retrospective study did not include a control group. Where applicable, measurements were compared with published normative reference values.

Measurements used to evaluate for ligamentous instability in the lower cervical spine (C2–C6) in flexion and extension, and the upper cervical spine (C1–C2) in lateral flexion with open mouth views, were obtained following DMX. DMX (videofluoroscopy) is a reliable method with a high degree of accuracy when assessing for cervical spine instability [30]. All patients had lateral X-ray imaging during maximum protraction to ensure the anterior atlantodens intervals were within normal range (<3 mm) [31]. Measurements to evaluate the state of cervical lordosis—depth of curve and forward head placement in relation to the lower cervical spine (C6-atlas interval)—were obtained following CBCT (Figure 4 and Table 1).

Figure 4.

Figure 4

Upright digital motion (fluoroscopic) X-ray (DMX) and cone beam computed tomography (CBCT) scan with structural measurements. (A) DMX positioning for open mouth lateral flexion. (B) CBCT setup. (C) Forward head (C6AI*) illustration. (D) C6AI measurement. (E) Depth of curve** illustration. (F) Depth of curve using DMX. (G) C1–C2 instability measurement. (H) Flexion, lower cervical instability. (I) Extension, lower cervical instability. * C6AI = horizontal distance in the sagittal plane of the posterior inferior C6 vertebra to anterior atlas (optimal is <10 mm). ** Depth of curve = horizontal distance in the sagittal plane from posterior inferior C4 vertebra to line drawn from posterior inferior C6 vertebra to top of dens (optimal is 7–17 mm). Figure copyright belongs to authors. (Reproduced from Ref. [29]).

Table 1.

Structural diagnostic imaging methods. Table copyright belongs to authors.

Measurement Modality and Output Criteria for Interpretation Application
Ligamentous Upper Cervical Instability (C1–C2) Lateral Flexion Upright digital motion X-ray (DMX, videofluoroscopy) of the cervical spine is used for identifying translation of adjacent vertebra (mm). Normal is <2 mm in any direction DMX allows structural deviations to be seen during movements and amongst different positions, which can document vertebral translations that could be putting strain on vital structures in the area. The upright position provides a high degree of accuracy which may otherwise be missed.
Ligamentous Cervical Instability (C2–C6) Flexion and Extension
Depth of Curve Upright cone beam CT of the cervical spine is used to identify distance from the posteroinferior aspect of the C4 vertebra to a line drawn from the posteroinferior aspect of the C6 vertebral body to the peak of the dens of C2 (mm). Normal is 7–17 mm Depth of curve is used to objectively assess the state of cervical lordosis.
C6-Atlas Interval
(C6AI)
Upright cone beam CT of the cervical spine used to identify
horizontal distance between the posterior border of the C6 vertebral body and a line drawn perpendicular from the anterior arch of the atlas in the sagittal view (mm).
Normal is <10 mm C6AI objectively assesses the structural relationship of the atlas in relation to the lower cervical spine (C6) in the sagittal plane, providing an objective measurement for “forward head posture” as it identifies to the position of the head, which sits upon the atlas, compared to the lower neck.

Neck vitals testing provided measurements of pupil diameters to assess for dilation and pupillary light response, optic nerve sheath diameters (ONSDs) for increased fluid around the optic nerve, internal jugular vein cross-sectional areas for structural compression and/or venous outflow obstruction from the brain, vagus nerve cross-sectional areas for degeneration, and intraocular pressure for increased pressure within the eye (Table 2).

Table 2.

Neck vitals analysis methods. Table copyright belongs to authors.

Measurement Modality and Output Criteria for Interpretation Notes/Application
Pupil Diameters NeurOptics NPi®-200
pupillometer automatically measures baseline pupil diameter (mm).
Normal is 2–4 mm unilateral in lit environments Chronically dilated pupils (mydriasis) can indicate sympathetic nervous system dominance/parasympathetic dysfunction (state of stress on the body).
Pupillary Light Reflex (Percent Change) NeurOptics NPi®-200
pupillometer automatically calculates the percent change in the pupil diameter after initiating a flash of light (%).
Normal is 15–30% unilateral Pupillary light reflex is used in clinical settings to assess for dysautonomia. Excessive percent change can be an indicator of sympathetic nervous system dominance.
Internal Jugular Vein Cross-sectional Area
(IJV CSA)
Canon Aplio a550 ultrasound with 7 MHz linear probe is used to identify cross-sectional areas in multiple positions including seated, supine, and with use of cervical orthotic (mm2). Normal is 90–100 mm2 unilateral Abnormally small IJV CSA is a cause of venous outflow obstruction, and indicative of external compression.
Vagus Nerve Cross-sectional Area
(Vagus nerve CSA)
Normal is >2.1 mm2 unilateral Atypical vagus nerve CSA is indicative of degeneration and low vagal tone.
Optic Nerve Sheath Diameter
(ONSD)
Canon ultrasound, ocular setting is used to identify the optic nerve sheath diameter (mm). Normal is <6.1 mm unilateral Elevated optic nerve sheath diameters can be indicative of increased cerebral spinal fluid and elevated intracranial pressure.
Intraocular Pressure
(IOP)
iCare ic200 tonometer automatically measures intraocular pressure (mmHg). Normal is <21 mmHg unilateral Elevated intraocular pressure can be indicative fluid outflow obstruction and/or elevated venous pressure.

2.2. Statistical Analysis

Data was analyzed using RStudio version 2024.04.2+764. Continuous variables were summarized using means and standard deviations, and categorical variables (e.g., number of symptoms) were summarized using counts and valid percentages. Statistical significance was defined as p < 0.05 for all tests.

We retained the full analytic sample (N = 84) and chose not to remove univariate outliers, as all values were clinically valid, accurately recorded, and confirmed through multiple quality checks. This decision was made to preserve the full range of clinical variations present in the sample, which reflects real-world patient presentations. Although some values were extreme, they did not result from data entry errors and were considered meaningful for analysis.

Missing data were handled using a pairwise deletion approach, meaning that each statistical test included all available cases for the variables involved. This approach preserved the maximum number of observations per analysis, and the sample size used in each test is reported accordingly.

Assumptions for parametric testing were evaluated. Skewness and kurtosis values for continuous variables fell within acceptable ranges (±3 and ±10, respectively). Normality of difference scores for paired comparisons were confirmed using Shapiro–Wilk tests (p > 0.05), and linearity of continuous variable relationships was verified using scatter plots. While certain variables showed non-normal distributions, Pearson correlations were appropriate due to the observed linearity in relationships and the robustness of this method in moderate-to-large samples.

To compare IJV CSAs across positions (C1 supine, C4–C5 supine, and C1 supine on Denneroll®, made in Wheeler Heights, NSW, Australia), paired t-tests were conducted. Because assumptions of normality for the paired difference scores were met, t-tests were the primary method of comparison. However, Wilcoxon signed-rank tests were also conducted as a robustness check. In all cases, parametric and non-parametric results were consistent, reinforcing the stability of the findings.

No covariates were included in the analysis, and subgroup or interaction effects were not examined due to the exploratory nature of the study. All analyses were conducted using raw, complete-case data without sampling weights or design-based corrections.

3. Results

Of the 84 patients included, 71 (85%) were female, 13 (15%) were male, average age 35 years, ranging from 20 to 50 years. Symptoms analysis showed that the top five reported symptoms at initial presentation were brain fog (95%), fatigue (94%), headaches (93%), concentration difficulty (92%), and neck pain (92%). A total of 83.1% of the patients self-reported more than 20 symptoms during their initial intake (Table 3).

Table 3.

Demographics and symptoms frequency at initial intake of 84 patients with hEDS at an outpatient neck center. Table copyright belongs to authors.

Demographics Count Percentage
Female 71 85%
Male 13 15%
Average age 35 -
Number of reported symptoms at initial intake from hEDS patients at an outpatient neck clinic (n = 84).
Number of Symptoms Count of Patients Percentage of Patients
0–9 2 2.4%
10–19 12 14.3%
20+ 70 83.3%
Symptom Count of Patients Percentage of Patients
Brain fog 80 95.2%
Fatigue 79 94%
Headaches 78 92.9%
Concentration difficulty 77 91.7%
Neck pain 77 91.7%
Anxiety 75 89.3%
Lightheadedness 75 89.3%
Dizziness 74 88.1%
Sleeping problems 73 86.9%
Muscles spasms/tension 72 85.7%
Neck grinding/cracking 70 83.3%
Sensitivity to light 70 83.3%
Digestion problems 69 82.1%
Irritability 68 81.0%
Nausea 67 79.8%
Stiffness in joints 67 79.8%
Balance difficulties 66 78.6%
Bruises easily 65 77.4%
Constipation 65 77.4%
Ringing in ears 65 77.4%
Insomnia 64 76.2%
Sensitivity to sound 64 76.2%
Blurred vision 63 75.0%
Dysautonomia 63 75.0%
Ear fullness/pressure 63 75.0%
Weakness 63 75.0%
Depression/hopelessness 61 72.6%
Eye pain/pressure 61 72.6%
Heart palpitations 60 71.4%

Analysis of clinical radiographic measurements gathered by retrospective chart review revealed 98.8% to have an increased (>10 mm) [32] C6-atlas interval (radiographic measurement of structural forward shift in the atlas in relation to lower cervical spine), 96.4% to have ligamentous cervical instability in lateral flexion at C1–C2 (>2 mm) [33,34], and 94.9% to have decreased depth of cervical lordotic curve (normal is 7–10 mm) [35,36].

Analysis of clinical objective neck vitals gathered from retrospective chart review showed elevated (>6.1 mm) [37,38] ONSD in 87.9% and 80.7% of participants on the left and right respectively, and slightly elevated pupil diameters (>4 mm) [39,40] in 95.2% in both left and right eyes. Vagus nerves were shown to be decreased (normal being >2.1 mm on right, >1.9 mm on left) [41,42] in 98.8% and 91.7%, respectively. The IJV CSA at C1 in the supine position was below normal limits (<90 mm) [43,44,45] in 91.7% and 95.2% on the left and right, respectively (Table 4).

Table 4.

Frequency of abnormal objective cervical structural and neck vitals test results in 84 patients with hEDS at an outpatient neck center. Table copyright belongs to authors.

Method N Normal Range Cutoff % Abnormal
C6-atlas interval * 82 <10 mm 98.8%
Depth of curve ** 79 7–10 mm 94.9%
Ligamentous cervical instability (LCI) Extension 82 <4 mm 52.4%
LCI Flexion 83 <4 mm 55.4%
Internal jugular vein (IJV) Denneroll® C1 total 80 >180 mm 90%
IJV supine C1 left 84 >90 mm 91.7%
IJV supine C1 right 84 >90 mm 95.2%
IJV supine C1 total 84 >180 mm 96.4%
IJV supine C4–C5 left 84 >90 mm 72.6%
IJV supine C4–C5 right 84 >90 mm 69%
IJV supine C4–C5 total 84 >90 mm 72.6%
Intraocular pressure left 84 <21 mmHg 34.5%
Intraocular pressure right 84 <21 mmHg 30.9%
Intraocular pressure total 84 <42 mmHg 34.5%
LCI C1–C2 lateral flexion left 84 <2 mm 89.3%
LCI C1–C2 lateral flexion right 84 <2 mm 88.1%
LCI C1–C2 lateral flexion total 84 <4 mm 90.2%
Optic nerve sheath diameter left 83 <6.1 mm 87.9%
Optic nerve sheath diameter right 83 <6.1 mm 80.7%
Optic nerve sheath diameter total 83 <12.2 mm 92.8%
Percent change total 84 30–60% 92.9%
Pupil diameter total 84 <8 mm 95.2%
Styloid length total 83 <60 mm 19.2%
Vagus nerve CSA left 84 >1.9 mm 91.7%
Vagus nerve CSA right 84 >2.1 mm 98.8%
Vagus nerve CSA total 84 >4.2 mm 100%

* Depth of Curve = horizontal distance in the sagittal plane from posterior inferior C4 vertebra to line drawn from posterior inferior C6 vertebra to top of dens (optimal is 7–17 mm). ** C6-Atlas Interval = C6AI = horizontal distance in the sagittal plane of the posterior inferior C6 vertebra to anterior atlas (optimal is <10 mm).

We also analyzed the mean and standard deviation of each cervical structural measurement and neck vitals test results, which revealed that many values fell outside the normal range, on average, within this patient cohort. The mean C6-atlas interval was 39.12 mm, which objectively measures the structural forward position of the atlas in comparison to the lower cervical spine, providing a radiographic measurement for evaluating forward head posture. Depth of curve mean was 1.58 mm, which objectifies loss of cervical lordosis. The mean ligamentous cervical instability at C1–C2 in lateral flexion (total, left and right) was 7.84 mm. Flexion and extension instability means were 5.29 mm and 4.41 mm, respectively (total from C2–C6, normal <4 mm). Flexion and extension instability (retrolisthesis anterolisthesis) are measured in maximum flexion and maximum extension. IJV CSAs in the supine position were decreased in all locations, the means being 40.97 mm2, 39.94 mm2, 67.91 mm2, and 71.48 mm2 at C1 left, C1 right, C4–C5 left, and C4–C5 right, respectively. Mean optic nerve sheath diameter was 7.28 mm and 7.17 mm on the left and right, respectively. Mean vagus nerve cross-sectional area was 1.34 mm2 and 1.22 mm2 on the left and right, respectively (Table 5).

Table 5.

Mean and standard deviation objective cervical structural and neck vitals test results in 84 hEDS patients at an outpatient neck clinic. Table copyright belongs to authors.

N Mean SD
C6-atlas interval (mm) 82 39.12 mm 12.18
Depth of curve (mm) 79 1.58 mm 3.24
Ligamentous cervical instability (LCI) Extension (mm) 82 4.41 mm 3.22
LCI Flexion (mm) 83 5.29 mm 3.38
IJV Denneroll® C1 left (mm2) 80 49.35 mm2 27.72
IJV Denneroll® C1 right (mm2) 80 55.73 mm2 30.84
IJV Denneroll® C1 total (mm2) 80 105.08 mm2 43.51
IJV seated C1 total (mm2) 84 19.55 mm2 11.74
IJV seated C4–C5 total (mm2) 84 21.00 mm2 14.84
IJV supine C1 left (mm2) 84 40.97 mm2 29.43
IJV supine C1 right (mm2) 84 39.94 mm2 25.03
IJV supine C1 total (mm2) 84 80.4 mm2 42.26
IJV supine C4–C5 left (mm2) 84 67.91 mm2 42.53
IJV supine C4–C5 right (mm2) 84 71.48 mm2 45.36
IJV supine C4–C5 total (mm2) 84 139.21 mm2 72.59
Intraocular pressure total (mmHg) 84 38.34 mmHg 8.31
Intraocular pressure left (mmHg) 84 19.14 mmHg 4.15
Intraocular pressure right (mmHg) 84 19.08 mmHg 4.15
LCI C1–C2 lateral flexion total (mm) 83 7.84 mm 3.18
Percent change/light constriction total (%) 84 74.92% 8.93
Percent change/light constriction left (%) 84 37.7% 6.05
Percent change/light constriction right (%) 84 36.8% 5.02
Optic nerve sheath diameter total (mm) 83 14.45 mm 1.64
Optic nerve sheath diameter left (mm) 83 7.28 mm 0.91
Optic nerve sheath diameter right (mm) 83 7.17 mm 1.00
Pupil diameter total (mm) 84 10.83 mm 1.79
Pupil diameter right (mm) 84 5.32 mm 0.86
Pupil diameter left (mm) 84 5.51 mm 0.99
Styloid length total (mm) 83 43.14 mm 28.35
Vagus nerve CSA total (mm2) 84 2.55 mm2 0.59
Vagus nerve CSA left (mm2) 84 1.34 mm2 0.38
Vagus nerve CSA right (mm2) 84 1.22 mm2 0.34

3.1. Comparisons

3.1.1. Vagus Nerve Cross-Sectional Area in hEDS vs. Control

An independent samples t-test was conducted to compare total vagus nerve CSA between patients with hEDS and healthy controls reported in a prior study (Bedewi, et al., 2023 [42]). Hypermobile Ehlers–Danlos syndrome patients had significantly smaller vagus nerve CSA (M = 2.55 mm2, SD = 0.59) than controls (M = 4.00 mm2, SD = 0.78), t(125) = −11.72, p < 0.001. The standardized effect size was Cohen’s d = −2.20, indicating a very large difference between groups. According to conventional benchmarks, values of d ≥ 0.80 are considered large, thus this result reflects a substantial reduction in vagus nerve size among this cohort of patients with hEDS compared to healthy individuals.

3.1.2. IJV CSA C1 Supine vs. IJV CSA Denneroll®

A Shapiro–Wilk test confirmed that the different scores between IJV CSA at C1 supine and C1 on Denneroll® were normally distributed (W = 0.98, p = 0.358), meeting assumptions for parametric analysis. A paired t-test revealed a statistically significant difference between the two positions, t(79) = −4.58, p < 0.001. The mean difference was −23.27 mm2, with a 95% confidence interval ranging from −33.38 to −13.16. These results indicate that, on average, IJV CSA at C1 while lying on the Denneroll® is significantly higher than IJV CSA at C1 supine. To confirm the robustness of this finding, a Wilcoxon signed-rank test was also conducted and yielded a consistent result, V = 719.5, p < 0.001 (Figure 5).

Figure 5.

Figure 5

Comparison of IJV C1 supine to IJV C4–C5 and C1 supine on Denneroll® showing that IJV CSA was significantly smaller at C1, and increased with use of cervical orthotic device, the Denneroll®, which is used to enhance the cervical curve. These comparisons suggest IJV CSA at C1 increases with improvement of cervical lordosis. Figure copyright belongs to authors.

3.1.3. IJV CSA C1 Supine vs. IJV CSA C4–C5 Supine

Similarly, the Shapiro–Wilk test indicated that the difference scores between IJV CSA at C1 and C4–C5 supine were normally distributed (W = 0.981, p = 0.240). A paired t-test showed a significant difference, t(83) = −8.83, p < 0.001. The mean difference was −58.82 mm2, with a 95% confidence interval of −72.06 to −45.57, suggesting that IJV CSA at C1 supine is significantly lower than at C4–C5 supine. The Wilcoxon signed-rank test confirmed this result, V = 275, p < 0.001, reinforcing the robustness of the finding across both mean and median comparisons (Figure 5).

4. Discussion

This study found that more than 90% of patients demonstrated abnormal findings of LCI C1–C2 lateral flexion, C6AI, and depth of curve, more than 95% had evidence of bilateral IJV stenosis and elevated ONSD, and 100% had abnormally small vagus nerve CSA, indicative of nerve degeneration/atrophy. The high prevalence and overlap of these structural abnormalities and test findings suggest these results are unlikely to be coincidental and raise the possibility that these findings may be mechanistically linked. We hypothesize that the findings likely represent cervical spine involvement contributing to the neurologic and autonomic features and systemic symptoms commonly found in hEDS.

Very little force (less than 1 Newton) is needed to completely compress a vein to occlusion, with 0.5 Newtons being enough to reduce venous outflow, equivalent to the very little force needed to click a pen [46,47] (Figure 6). As little as 0.5 Newtons has also been shown to cause compression injury on nerves, with effects of reducing conduction velocity, decreasing microvascular flow, and altering myelin structure from mechanical shear force [48,49].

Figure 6.

Figure 6

Very little force (less than 1 Newton) is needed to completely compress a vein to occlusion, with 0.5 Newtons being enough to reduce venous outflow. As the posterior ligaments of the cervical spine become damaged (red), the atlas shifts forward in 3-D space (arrow), causing compression of the internal jugular vein. Figure copyright belongs to authors.

The IJVs and vagus nerves run within the carotid sheath and do not have cartilage protection, making them vulnerable to compression and injury. We postulate that the cervical structural abnormalities (LCI, depth of curve, and C6AI) documented in this study cause compression of the carotid sheath, primarily due to a forward shift in the atlas, documented as decreased CSA of the vagus nerves and IJVs. (Figure 7). Collectively, these findings suggest that cervical spine structural abnormalities may underly this cohort’s multisystem symptomatology, pointing toward potential involvement of impaired venous outflow and altered autonomic regulation due to IJV compression and vagus nerve degeneration, respectively.

Figure 7.

Figure 7

Structural changes in the cervical spine, including a forward shift in the atlas due to ligamentous cervical instability, can cause compression of the internal jugular veins (IJVs) and vagus nerves. Figure copyright belongs to authors.

A comparison of IJV CSAs at C1 and C4–C5 showed that supine IJV CSA C1 total (IJV bilateral totals at the atlas) was significantly smaller than in the mid-cervical region (C4–C5), with an average difference of 58.82 mm2 (p < 0.001), suggesting IJV compression at C1. This comparison shows that IJV compression could be missed if IJV CSA is only evaluated at the mid-neck region, where ultrasound evaluation of the IJV is most often utilized [50].

The significantly smaller average vagus nerve CSA (bilateral total of 2.55 mm2) in this cohort compared to an asymptomatic, healthy, demographically similar population’s average vagus nerve CSA (4.0 mm2) indicates the presence of vagus nerve degeneration (p < 0.001) [42].

More than 83% of our cohort reported more than 20 symptoms on initial presentation, the top five being brain fog, fatigue, headaches, concentration difficulty, and neck pain. Chronic disabling symptoms involving the musculoskeletal, ocular, cardiovascular, gastrointestinal, and other body systems and organs are many times more prevalent in hEDS vs. the general population, as seen in our cohort: brain fog (95% vs. 28%), fatigue (94% vs. 10%), headaches (93% vs. 52%), concentration difficulty (92% vs. 14%), and neck pain (92% vs. 30–50%) [11,51,52,53,54,55,56,57] (Figure 8). The symptoms reported in this study (and others) are frequently concurrent comorbidities in hEDS patients, and many co-occurring conditions act as disabling conditions on their own, which adds to treatment difficulties and emphasizes the systemic burden of hEDS [2].

Figure 8.

Figure 8

Symptom frequencies in this hEDS cohort compared to general population. Figure copyright belongs to authors.

We suspect the documented LCI, breakdown of the cervical curve (decreased depth of curve), and forward head posture (measured as C6AI) contributes to a forward shift in the atlas in 3-D space, putting stretch and compression on the soft tissues and neurovascular contents of the neck, including the carotid sheath, containing the IJVs and vagus nerves. The right and left carotid sheaths contain the internal carotid artery, internal jugular vein, vagus nerve, glossopharyngeal nerve, and spinal accessory nerves. This dynamic carotid sheath compression, which refers to carotid sheath compression with certain head and neck positions that compromise the structures within the carotid sheath, could be one explanation for many symptoms of hEDS, potentially accounting for various brain and body diseases and symptoms, including many seen in this patient cohort: headaches, brain fog, concentration difficulty, vision issues, lightheadedness, fatigue, memory problems, tinnitus, sleep disturbances, anxiety, depression, heart palpitations, gastrointestinal problems, chronic pain, and more [32,58,59,60,61,62,63,64,65] (Figure 9).

Figure 9.

Figure 9

Potential ligamentous cervical instability etiology for many diseases and symptoms of the brain and body in hypermobile Ehlers–Danlos syndrome [32,58,59,60,61,62,63,64,65]. Figure copyright belongs to authors.

Various explanations have been put forth regarding the diverse symptomatology in hEDS, including genetic and nongenetic factors, recent findings connecting kallikrein genes, faulty collagen making the ligaments more stretchy, neurovascular dysfunction, increased vascular endothelial permeability, gastrointestinal hypermobility, neuromuscular proprioceptive defects, autonomic nervous system dysfunction (dysautonomia), histamine dysregulation, soft tissue lesions (e.g., bursitis, tendonitis, synovitis, tenosynovitis, and fasciitis), fascial, vascular, and inflammation [17,66,67,68,69]. We propose that dynamic carotid sheath compression could either be a primary structural etiology or act as a contributing factor alongside the other mechanisms outlined above. Further studies are needed to determine clinical relevance of cervical dysstructure, IJV compression, and vagus nerve degeneration in patients with hEDS.

4.1. Ligamentous Cervical Instability

This is the first study that documents ligamentous facet joint cervical instability at C1–C2 (LCI C1–C2) in a cohort of hEDS patients. Recently, spinal deformities in EDS are being addressed more prominently, but without specific details on hEDS or facet joint instability [70]. The previously documented ligamentous cervical instabilities in EDS patients are of the atlantodens, which often require surgical intervention and differ from our cohort, where instability of the facet joints was documented [71]. In the medical literature, atlantoaxial instability usually refers to ligamentous atlantodens (or central or medial atlantoaxial) instability, describing the relationship between the atlas, dens, and medial joint location, primarily stabilized by the transverse and alar ligaments [72,73]. In contrast, the atlantoaxial facet joints (left and right) are located laterally and stabilized by the capsular ligaments, and thus the condition is also known as lateral atlantoaxial instability when injured [74,75,76] (Figure 10). The distinction between the two different types of C1–C2 instability is important because atlantoaxial instability is typically a surgical lesion, whereas atlantoaxial facet joint instability can often be treated by conservative measures such as chiropractic care, physiotherapy, and prolotherapy [71,77]. In this cohort, patients were clinically confirmed to not have atlantoaxial instability by measuring the atlantodental interval during clinical testing and confirming each patient had less than 3 mm, which is the standard cutoff to be considered abnormal in adults [78].

Figure 10.

Figure 10

Ligamentous atlantoaxial (C1–C2) facet vs. medial atlantodens joint instability. Figure copyright belongs to authors.

Diagnostic and management complexities of craniocervical instability in EDS patients have been previously discussed, largely highlighting the under-researched aspects of the conditions, and a need for greater consensus and guidelines to be validated regarding when surgery is necessary and to explore other potential treatment strategies [79]. A high percentage of hEDS patients who undergo spine surgery report complications (42.9% in a cohort of more than 1300 patients) [14].

In our patient population, we performed dynamic upper cervical functional fluoroscopy, which demonstrated stable anterior atlantodens joints (<3 mm distance between arch of C1 and dens of C2 on maximum protraction views) but significantly unstable C1–C2 facet joints (>2 mm translation/overhang of C1 on C2 on lateral flexion views) [80,81]. Congenital capsuloligamentous laxity is the primary articular feature of hEDS [82]. Ligamentous upper cervical instability is a common finding in severely symptomatic hEDS patients, already thought to complicate EDS presentation [64,83]. LCI is characterized by vertebral translation > 2 mm in one direction, defined by the degree of overhang by an adjacent vertebra, though this criterion still needs further clinical validation, as some patients can be symptomatic with less translation [30,33,84]. Some centers consider a difference of ≥1 mm between maximum flexion and extension x-rays to be diagnostic [34]. Our patient population had both extension and flexion LCI, demonstrating > 1 mm of difference between vertebrae at multiple levels, as well as C1–C2 facet joint instability. Highly suggestive symptoms of ligamentous upper cervical instability include heavy head/bobblehead, apprehension of neck movement, difficulty swallowing, clicking/grinding in the neck, sensorimotor symptoms such as a pulling sensation of the head/neck, numbness/tingling, vision changes, cognitive changes, drop attacks, and more [85]. Symptoms of ligamentous upper cervical instability may increase with forward head posture, leaning forward, neck motion, neck flexion, or being upright without neck support [85].

The musculoskeletal manifestations of hEDS are widespread, often culminating in a high percentage of patients having chronic pain and neurological symptoms, which was seen in the 92% of this cohort having chronic neck pain, headaches, and concentration difficulty, 95% having brain fog, and more than 85% having dizziness, anxiety, lightheadedness, and much more [86,87]. Emerging evidence shows upper cervical spine morphology to be affected in hEDS patients significantly more often than in controls, joint instability and muscle imbalances being potential contributors to forward (extended) head posture, which may worsen cervical pain and dysfunction [9]. Based on this study, one possible cause of pain could arise from the nociceptors (from the Latin nocere, “to harm or hurt”) in the ligaments: 50% of the these sensory neurons are in C1–C3 region, the very area where the most significant ligament instabilities were found in this cohort [88,89].

The combination of the capsuloligamentous issues in hEDS compounded with the multidimensional (flexion, extension, and lateral flexion) ligamentous cervical instabilities found in this cohort could contribute to the development of structural forward head posture (increased C6AI) and loss of cervical lordosis (decreased depth of curve) [90]. As a person tilts their head forward, the forces on the craniocervical junction are amplified, eventually causing long-lasting stretching, assumed to be especially hazardous to joint stability [91]. A 15° tilt, for instance, causes the average head to feel like 27 pounds, and at a 45° tilt, it feels like it weighs around 49 pounds [92]. A forward head posture puts strain on the posterior cervical ligaments, potentially leading to a breakdown of the normal cervical lordotic curve, the cumulative structural changes being termed “cervical dysstructure.” [93]. In theory, then, simple daily facedown/forward head posture, such as looking down at a phone held a lap, is a long-term and repetitive amplified force on the craniocervical junction, which could lead to cumulative structural changes that likely stem from ligament damage. Unless something is done to stop the process of abnormal forces on the cervical spine causing the ligament laxity and the structural changes, cervical dysstructure will likely be progressive, and so could be the symptomatology [91] (Figure 11).

Figure 11.

Figure 11

Joint hypermobility may progress into ligamentous cervical instability due to excessive forces on the cervical spine, and ligamentous cervical instability will continue to progress unless the forces from the cervical dysstructure are relieved. Figure copyright belongs to authors.

Cervical spine instability in hEDS is already attributed to ligament laxity [94]. A 2023 study observed that patients with radiographically confirmed upper cervical instability (using DMX) and loss of cervical curve after trauma showed improvement in both cervical lordosis and upper cervical instability following a cervical curve correction regimen, as well as statistically significant symptomatic and functional improvement, supporting the link between these two measures and clinical outcomes [95]. Further studies are needed to elucidate the possible interrelationships between ligamentous upper cervical instabilities, increased C6AI (forward head), and decreased depth of curve (loss of lordosis). Additionally, future research should assess the effects of those structural changes on the soft tissues, nerves and vasculature in the neck, and clinical outcomes following cervical structural restoration.

4.2. Internal Jugular Vein Compression at C1 Involvement in hEDS Patients

The overwhelming frequency of documented IJV compression at the level of C1 in this patient cohort suggests venous obstruction as a contributing factor to hEDS symptoms. The IJVs span the cervical spine medial to the lateral mass of C1, running along the transverse process of C1, which is where most IJV compression occurs [96]. IJV compression was documented at the level of C1 (atlas) in 96.4% of this cohort, while 92.8% displayed elevated ONSD. Elevated ONSD was not a surprising finding, given the frequency of IJV compression, which is understood to be a mechanism of inhibiting cerebral venous outflow, including cerebrospinal fluid (CSF) drainage [97] (Figure 12). Based on these findings, we suspect venous and CSF drainage to be impaired in this cohort due to the IJV compression from a forward shift in the atlas, given the smaller IJV CSA values at C1 which could cause increased intracranial pressure and resultant increased ONSD. IJV compression is one mechanism which may explain some of the brain-based symptoms experienced by the patients in this study, including headaches, brain fog, concentration difficulty, fatigue, dizziness, blurred vision, depression, and anxiety [98,99,100].

Figure 12.

Figure 12

Elevated optic nerve sheath diameter (ONSD) is indicative of elevated intracranial pressure. Figure copyright belongs to authors.

There are many ways in which IJV compression could cause functional and structural brain impairment, including raising intracranial pressure, decreasing cerebral perfusion, causing change in cerebrospinal fluid dynamics, inciting cerebral microvascular structure impairment, and contributing to a breakdown of the blood–brain barrier, among others [101,102,103] (Figure 13). Structural and functional brain changes are frequently present in hEDS, specifically disrupted CSF flow and craniocervical instability [62]. Approximately 70–80% of intracranial fluid flows through the venous system, with around 70% of blood exiting the brain through the IJVs in the supine position [104]. Compression of the IJVs in the supine position is an established cause of elevated intracranial pressure, which was seen in this patient cohort, suggesting it may be a missing underlying cause of many hEDS symptoms [105].

Figure 13.

Figure 13

IJV compression due to unresolved ligamentous cervical instability/dysstructure can cause functional and structural brain impairment. Figure copyright belongs to authors.

Transorbital ultrasonographic examination of the ONSD as used in this study is a reliable, noninvasive diagnostic tool employed in many settings to detect elevated intracranial pressure, which is shown to correlate with invasive and noninvasive measurements of intracranial pressure [106,107,108]. Increased ONSD is indicative of elevated intracranial pressure because it provides a picture of increased CSF accumulated around the optic nerve through the subarachnoid space. The mean ONSDs in this cohort were 7.28 mm and 7.17 mm on the left and right, respectively. The established normal unilateral ONSD values in healthy adults range from <5.0–5.4 mm [109]. When evaluating for elevated intracranial pressure, the widely accepted cutoff value used in emergency rooms and other settings ranges from >5.6–6.0 mm, although some have found as low as >5.3–5.7 mm to be correlated with elevated intracranial pressure > 20 mmHg (normal is 10–15 mmHg) [108,110,111,112]. This finding of elevated ONSD supports the idea that increased intracranial pressure contributes to the clinical characteristics of the patients in this cohort [113]. Similar findings of IJV compression at C1 and an increase in ONSD were found in a separate cohort of patients with symptoms of anxiety, brain fog, concentration difficulty, depression, headaches, obsessive thoughts, panic attacks, and rumination [32,114].

The internal jugular veins are easily, noninvasively, and reliably measured using B-mode ultrasound, as utilized in this study [115] (Figure 14). Normal IJV CSA in the supine position is >90–100 mm2 and approximately 25 mm2 in the upright position [44,116]. These data show that the cross-sectional area using ultrasound of the IJVs in the mid-neck (C4–C5) and upper neck (C1–C2) in both a seated and supine position and with different head and neck positions can determine not only if the IJVs are being compressed, but by how much and which positions and locations are worse.

Figure 14.

Figure 14

Internal jugular vein (IJV) cross-sectional area (CSA) measurement using ultrasound in various head and neck positions. (A) Upright measurement at the C4–C5 level. (B) Upright measurement at the atlas (C1) level. (C) Supine measurements at the C4–C5 level while lying on the Denneroll®. (D) Supine measurements at the C1 level. (E) Supine measurements at the C1 level while lying on the Denneroll®. The internal jugular vein is typically much more open in the supine position compared to upright, and when there is a breakdown of the cervical curve (dysstructure) and/or ligamentous cervical instability, the IJV gets maximally compressed at the atlas. Figure copyright belongs to authors. (Reproduced from Ref. [29]).

This cohort demonstrated significant improvement in IJV CSA at C1 when lying on a cervical orthotic device, the Denneroll®, compared to supine without it (105.1 mm2 vs. 80.4 mm2, p < 0.001). By lying on the Denneroll®, a cervical extension traction device, the cervical curve is encouraged to go into lordosis, a documented type of therapy primarily used in chiropractic treatment to improve cervical lordosis and relieve symptoms from forward head posture, such as chronic pain [117,118,119] (Figure 15). The increased IJV CSAs seen in this study when lying on the cervical orthotic device support the notion that cervical structural changes are a cause of venous obstruction, which may be corrected by restoring the cervical lordotic curve. We further hypothesize that by following a curve correction program and restoring structural integrity of the cervical spine to maintain proper lordosis, the IJV compression by the atlas should be relieved, potentially accompanied by a reduction in symptoms.

Figure 15.

Figure 15

Supine images demonstrating correlation of internal jugular vein compression with cervical dysstructure severity and improvement with Denneroll®. Figure copyright belongs to authors.

Cerebral venous outflow obstruction is well established to coexist with connective tissue disorders and can account for many symptoms such as headache, dizziness, tinnitus, and cognitive dysfunction [120]. Cervical IJV compression at the C1 transverse process (also identified in the current literature as between the C1 transverse process and the styloid process) is associated with many clinical manifestations, including such nonspecific neurological symptoms as neck pain, headache, visual disturbances, headaches, dizziness, and mental health conditions, though the etiology is often unspecified [96,121]. In a study of 108 consecutive patients undergoing CT angiography for presumed arterial obstruction, 50% of them had IJV compression, and 93% of the compressions were at the level of C1 [122]. Cerebral venous outflow obstructions, including those in the IJVs, are also increasingly recognized in cases of intracranial hypertension that were previously identified as “idiopathic.” [123,124] Many symptoms from this condition, including headache, tinnitus, dizziness, and cognitive dysfunction, improve dramatically with restoration of IJV and cerebral venous outflow [125,126,127]. Intracranial pressure reduces, and related symptoms such as headache, tinnitus, and optic papilledema may resolve following IJV stenting or styloidectomy, the main surgical treatments for internal jugular vein stenosis/styloid-jugular venous compression syndrome, though the long-term outcomes are unknown, highlighting the importance of further investigating underlying causes in order to advance innovative treatments [127,128,129]. In a study involving lumbar puncture positioning, neck flexion produced an intracranial pressure 15.2 mmHg higher than when straightening the neck in the same seated position, evidence that cervical structural position influences brain pressure [130].

Tonometry, or intraocular pressure, was included in this study because of its often-direct relationship to intracranial pressure; for instance, both are increased by IJV compression [131,132]. In about two-thirds of cases, a rise in intraocular pressure is associated with a rise in intracranial pressure [133]. In this study, the average bilateral total intraocular pressure was 38.34 mmHg (normal being < 42.0 mmHg), with no significant differences seen between left and right eyes, while 34.5% of patients had ocular hypertension (intraocular pressure > 42.0 mmHg). While the actual measurements of tonometry, pupillometry, and IJV and vagus nerve CSA are done individually (right, then left), they are reported and discussed here as bilateral totals to streamline comparisons, since there was no statistically significant difference found between right- and left-side measurements. We postulate that the reason for the bilateral findings is due to the concurrent findings of ligamentous cervical instability, forward head posture, and loss of cervical lordosis (Figure 16). This is the first study to document not only IJV CSA, but also ONSD and intraocular pressure in patients with hEDS and chronic symptoms. If validated by further prospective studies, the identification of IJV compression as an underlying contributor to the clinical characteristics of hEDS patients would be of significant clinical relevance, as it would highlight a potentially modifiable pathology with implications for improved patient outcomes.

Figure 16.

Figure 16

Cervical dysstructure is likely to cause bilateral pathophysiology due to the symmetrical nature of the cervical spine and its contents. Figure copyright belongs to authors.

4.3. Vagus Nerve Involvement in hEDS Patients

This is the first time ultrasound vagus nerve CSA has been reported in a cohort of patients with hEDS, a remarkably novel finding as 100% of the patients in this study had evidence of bilateral vagus nerve degeneration (atrophy). Normal cross-sectional areas of the vagus nerves in healthy adults average between 1.9 and 2.5 mm2, the right often larger than the left [37,42]. This patient population presented with significantly decreased vagus nerve CSA, with averages of 1.22 mm2 on the right and 1.34 mm2 on the left and a total bilateral average of 2.55 mm2. The vagus nerves are very susceptible to compression and degeneration, which can be documented by ultrasound of the carotid sheath [134,135]. A decrease in vagus nerve CSA is found to correlate with parasympathetic dysfunction, which may explain many symptoms present throughout this patient population [41]. The vagus nerves are the dominant nerves of parasympathetic nervous system, accounting for 80–90% of its afferent fibers, and are the primary inhibitor of sympathetic stimulation [136]. Degeneration or dysfunction of the vagus nerves, resulting in reduced vagal activity, could then lead to a sympathetic-dominant state. Hyperactivity of the sympathetic system and/or parasympathetic hypoactivity causes sympathovagal imbalance, something seen in a host of brain and body diseases, including mental health disorders [136,137,138]. Damage to the vagus nerves, or decreased vagal signaling, results in impaired anti-inflammatory effects or excessive production of inframammary cytokines [139]. The potential sympathetic dominance and excessive systemic inflammation may contribute to many of hEDS patients’ constellation of symptoms, including joint pain, gastrointestinal disturbances, fatigue, and more, due to the vagus nerves’ role in the brain–body connection and in regulating inflammation [140,141].

The mystery of the symptoms of hEDS often leads to the diagnosis of functional neurologic or gastrointestinal disorders [142]. Vagus nerve dysfunction can affect nearly every organ in the body, with consequences including abnormal heart rate and blood pressure, digestive issues, loss of respiratory control, and chronic pain, which may explain the high correlation between joint hypermobility and functional neurologic disorders [143,144]. In the latter, the symptoms are real, but there is not an identified structural problem or organ damage; it is thought to be a brain function or network communication problem, which could be from overlooked dysfunctional vagus nerves [145]. While the term “functional” often denotes psychological or unbeknownst neurologic dysfunction, our study could offer an explanation that there is a structural vagopathy.

The decrease in vagus nerve CSA can be explained in our cohort by the dynamic carotid sheath compression, which occurred primarily at the atlas, the very position where the two vagus nerve ganglia reside. The superior (jugular ganglion) is located in the jugular foramen and the inferior (nodose ganglion) sits right in front of the atlas. The nodose ganglion carries crucial sensory information from the internal organs, including the heart, lungs, and digestive tract [144].

Research shows that up to 98% of hEDS/hypermobile spectrum disorder subjects had functional gastrointestinal disorders, compared to 47% of controls [146]. Functional neurological symptoms are present in up to 92% of hEDS patients [142,147]. Dynamic carotid sheath compression, which can occur when the neck becomes chronically flexed, puts the contents of the carotid sheath, as well as other neurovascular structures, under constant stretch and tension. It could be one reason why many hEDS patients are diagnosed with functional disorders, such as functional internal organ or neurological disorders, meaning the symptoms are severe but they are not caused by a recognizable organ disease or injury [142].

Up to two-thirds of EDS patients have evidence of small fiber neuropathy [148]. Small-fiber dysfunction has been indicated to worsen dysautonomia and vascular maladaptation in hEDS [149]. Symptoms such as weakness, fatigue, seizures, and sensory disorders documented in so-called “functional neurologic disorders” where no structural abnormalities are identified in scans such as brain, brainstem, and spinal cord MRIs, could be explained by dynamic carotid sheath compression from ligament laxity [150]. In functional neurologic disorders, the condition remains largely unexplained, but the nervous system does not function properly, leading to symptoms such as weakness, fatigues, seizures, and sensory issues [142,150,151]. Some studies have found exaggerated stress reaction (somatosensory amplification, or brain hypersensitivity syndrome) in patients with hypermobility syndromes, which we propose could have underlying cerebral neuropathology from IJV compression and resultant increased intracranial pressure or vagus nerve degeneration [152,153,154].

Dysautonomia and autonomic nervous system dysfunction are frequent extraarticular manifestations of hEDS [61,155]. Some 75% percent of our cohort was diagnosed with dysautonomia; the prevalence in hEDS ranges from 31 to 94% [17]. Dysautonomia or autonomic nervous system dysfunction can have many different etiologies, including those involving cardiac, endocrine and immune systems, brainstem and spinal reflexes, fluid status, and many others [156]. Patients with hEDS and dysautonomia were found by standard autonomic nervous system tests such as heart rate variability (frequency domain) to have a higher LF/HF ratio at rest, a sign of increased sympathetic/parasympathetic activity compared to controls [66]. The vagus nerves traverse the neck just anterior to the cervical vertebrae, as do the IJVs, and are subject to injury from stretch and compression, as all nerves are [157]. Vagus nerve CSA can be seen using ultrasound, as utilized in this study. (Figure 17). Based on the findings of vagus nerve degeneration and cervical structural abnormalities in this cohort, we propose an additional potential cause of dysautonomia to be cervicovagopathy—vagus nerve degeneration secondary to cervical pathology [158].

Figure 17.

Figure 17

Ultrasound of vagus nerve (red arrows) in mid-cervical region with various neck positions. (A) Neck in neutral position. (B) Flexed neck. (C) Neck extended. (D) Neck rotated left. (E) Neck rotated right. As can be seen, the vagus nerve within the carotid sheath undergoes various structural tensions depending on neck positions. Figure copyright belongs to authors. (Reproduced from Ref. [29]).

Patients with dysautonomia are known to have a plethora of symptoms involving the cardiovascular, gastrointestinal, neurological, cognitive, and other body systems, with hEDS and other hypermobility syndromes being a common co-morbidity [159,160]. In a different cohort of patients with anxiety, dizziness, fatigue, irritability, lightheadedness, insomnia, sleeping difficulty, neck pain, and neck cracking and grinding, vagus nerve atrophy (degeneration) was also overwhelmingly present [158]. Vagus nerve degeneration has been found in progressive neurodegenerative disorders, and vagus nerve stimulation has been used for treatment of those disorders, as well as for symptoms such as anxiety, depression, and headache [161,162,163,164]. Although reduced vagus nerve CSA was observed, functional autonomic testing was not available in this retrospective dataset. The relationship between structural findings and vagal function in this cohort cannot therefore be determined. Future prospective studies incorporating standardized autonomic assessments are needed to evaluate potential functional implications in hEDS.

The pupillometry findings observed in this study may be suggestive of a sympathetic dominant state, with pupil diameter bilateral totals averaging 10.83 mm (normal is <8 mm) and bilateral total percent constriction to light averaging 74.9% (normal is 30–60%), both in the “high end” of normal or slightly above normal [165,166]. Pupillometry has been used to document such conditions as acute rises in intracranial pressure, as also occurs after trauma or in intensive care units following brain surgery. It is also a non-specific indicator of sympathetic hyperactivity [167,168,169]. While these findings alone do not confirm sympathetic dominance, pupillometry may be included in future studies involving similar patient cohorts, where symptoms suggestive of sympathetic dominance are prevalent, to further assess clinical relevance.

As we previously described, when vagus nerve dysfunction is caused by structural neck (cervical spine) issues, it is called “cervicovagopathy” [158]. We suspect many symptoms in this patient population with hEDS could be caused by vagus nerve degeneration, and therefore autonomic dysfunction. (Figure 18). Validation of vagus nerve degeneration as an underlying factor would not only clarify a pathophysiological basis for the frequent presentation of dysautonomia and myriad symptoms seen in hEDS, but it would also serve as a target for intervention that could improve clinical outcomes. If vagus nerve degeneration is in fact due to cervical stretch and compression from a cervical spine pathology, then a multifaceted treatment program may include ergonomics, postural exercises, a vagus nerve stimulator, and prolotherapy, with an overall aim of correcting the underling cervical dysstructure (such as restoring cervical lordosis and stabilizing identified ligamentous cervical spine instabilities), thereby reducing stretch and compression of the nerves [158].

Figure 18.

Figure 18

Vagus nerve degeneration and autonomic imbalance in hypermobile Ehlers–Danlos syndrome. Figure copyright belongs to authors.

4.4. Clinical Relevance and Future Directions

While previous studies have described joint hypermobility/instability and cervical spine instability associated with complications in hEDS patients, as well as autonomic, cerebrovascular, and neuropathic features of hEDS, consideration of the structural mechanistic framework for the widespread multisystem presentation of the condition has been limited [11,18,25,79,94,142,147,170]. This study builds on the current literature and aligns with prior observations from specialists managing this challenging and poorly understood patient population, suggesting that upper cervical insatiably may be an important contributor to the complex clinical profile in a subset of the hEDS patients [71,79,85,171].

The findings offer novel evidence that cervical spine abnormalities could contribute to the understanding of multisystem involvement in hEDS, including involvement of the autonomic nervous system via the vagus nerves and of cerebral venous outflow obstruction via the IJVs. Given that patients with hEDS are inherently prone to upper cervical spine morphology, these findings may help elucidate the consequences of that vulnerability. It is plausible to consider how the structural cervical spine changes lead to a forward-shifted atlas encroaching on the carotid sheath, causing neurologic and vascular compression, substantiated by the documented ligamentous cervical instability, forward head posture, and loss of cervical lordosis in this cohort.

By highlighting previously underrecognized potential mechanisms, these findings could help address an existing gap in the treatment of hEDS, especially in the clinical context of otherwise elusive symptoms and complex cases. Ultimately, we propose that correction and stabilization of the cervical spine structure in patients with hEDS could help relieve symptoms stemming from ligament laxity/ligamentous instability in the cervical spine and relieve the potentially consequential IJV compression and vagus nerve degeneration. Prolotherapy is considered a regenerative injection technique that initiates the body’s natural three-phase healing process of inflammation, proliferation, and remodeling to create a controlled inflammatory response that encourages tissue repair in areas with poor blood supply, such as ligaments, tendons, and cartilage [172,173]. Prolotherapy has been shown to increase ligament strength and has been used successfully in cervical conditions, including instability [174,175,176,177,178].

This study highlights the need for larger prospective studies on underlying cervical spine pathology and its pathophysiological effects in patients diagnosed with hEDS, as well as potential improvement following cervical spine corrective treatment. The testing methods described in this study are objective, noninvasive, and reproducible. They can be done serially to check patient progress. Structural–neurovascular relationships similar to those observed in this hEDS cohort may warrant investigation in other conditions involving cervical instability, degenerative changes, or altered biomechanics, such as acquired ligament laxity and cervical spondylosis. Hypothetically, if cervical neck structure, including ligamentous cervical instability and cervical dysstructure, are the etiology of some widespread symptoms, then improving cervical lordosis and ligamentous stability should decrease or resolve them. If future studies demonstrate that improvements in neck structure, such as restoring cervical lordosis and improving stability, lead to IJV and vagus nerve CSAs’ improvement that corresponds with symptom improvement, then a great step forward in the alleviation of chronic and disabling hEDS symptoms would occur. We emphasize these data to be hypothesis-generating and that comparative, prospective studies will be necessary to determine the presence, magnitude, and clinical relevance of these observed structural and neurovascular associations.

5. Limitations

This study was designed as a descriptive, cross-sectional characterization of initial clinical test findings. Given the retrospective nature of the study, the findings cannot determine causation; they only describe associations. No inferential subgroup analyses were pre-specified. Although symptom presentation was clinically heterogeneous, the primary aim was to describe overall patterns of structural and neurovascular measurements within this cohort for consideration of potential underlying mechanisms contributing to hEDS, rather than to evaluate symptom-specific associations. Future studies with larger samples may be better positioned to examine subgroup differences.

Formal autonomic testing was not systematically collected as part of routine clinical care to assess vagus nerve function and were therefore not available for analysis in this dataset. As such, we are unable to directly correlate vagus nerve cross-sectional area with functional measures. We did not examine what led to the forward head posture, loss of lordosis, or LCI, but one could speculate that the modern lifestyle that includes excessive time spent in poor posture using computers and cell phones could contribute, compounded by the fact that patients with hEDS are predisposed to ligament laxity [179]. As data were collected from a single outpatient neck center, the findings may not be fully generalized to all clinical populations, though they do provide insight into a subset of patients with chronic, disabling symptoms who present with hEDS in the absence of other known mechanisms, highlighting interdisciplinary clinical relevance. Imaging interpretation was not performed under blinded research conditions. Although the imaging modalities used have established reliability in prior studies, the absence of formal blinding may introduce observer bias. Since this study is a retrospective chart review conducted at a single institution, inter-rater reliability was not formally calculated, although standardized data collection protocols were used.

The lack of an internal control group and matched comparisons limits causal interpretation of the observed associations. While we did exclude patients with previous neck injury, surgery, or trauma, potential confounding variables (such as medications, prior interventions, and lifestyle) were not fully stratified. Further, the absence of detailed genetic profiling limits the ability to exclude potential coexisting genetic factors that may contribute to the observed clinical features. This study does not include follow-up data to evaluate symptom progression or response to treatment. Future prospective studies with appropriate controls and predefined stratification strategies will be necessary to determine the specificity and mechanistic relevance of these findings. Further longitudinal studies are necessary to explore potential treatment options such as physical therapy, chiropractic adjustments, cervical curve correction, and prolotherapy, targeting restoration and stability of the cervical curve to relieve the pressure on vital neurovascular structures (IJV and vagus nerve) and evaluate efficacy.

6. Conclusions

This retrospective study is the first to quantify and document ligamentous facet joint cervical instability at C1–C2, evidence of IJV compression at C1, and vagus nerve degeneration in a cohort of patients with hEDS. Radiologically identified loss of cervical lordosis and forward head posture were also ubiquitous. More than 70% of patients reported more than 29 symptoms, emphasizing the systemic effects of the condition. The consistency of the cervical spine pathology and neurovascular abnormalities throughout the entire cohort supports potential cervical spine involvement in hEDS presentation. Recognition of cervical spine pathology in patients with hEDS may present patients with new targeted treatment options. Future prospective studies are needed to validate these associations and clarify underlying mechanisms contributing to the chronic symptomatology of hEDS, which could inform diagnosis, treatment, or preventative strategies. If cervical spine pathology proves to cause contributing mechanisms leading to complications, then nonsurgical correction of the cervical curve and cervical spine stabilization should be considered as part of a multidisciplinary approach to patients with hEDS.

Acknowledgments

The authors would like to thank Kerstyn Gay for contributing graphic designs to this article.

Author Contributions

Conceptualization, R.A.H.; Methodology, R.A.H.; Validation, R.A.H. and M.G.; Formal Analysis, A.W.; Investigation, R.A.H. and D.M.; Resources, R.A.H. and D.M.; Data Curation, R.A.H.; Writing—Original Draft Preparation, R.A.H. and M.G.; Writing—Review and Editing, B.R.R. and M.G.; Visualization, R.A.H., M.G. and B.R.R.; Supervision, R.A.H.; Project Administration, R.A.H. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the WIRB-Copernicus Group (WCG) Institutional Review Board (Study #20252006) on 20 May 2025.

Informed Consent Statement

Informed consent was obtained from the subjects after an explanation of the nature and possible consequences.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

Authors Ross A. Hauser, Danielle Matias, and Benjamin R. Rawlings were employed by the company Caring Medical Florida, LLC. Morgan Griffiths was an independent researcher contracted by Caring Medical Florida, LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding Statement

This research received no external funding.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Martín-Martín M., Cortés-Martín J., Tovar-Gálvez M.I., Sánchez-García J.C., Díaz-Rodríguez L., Rodríguez-Blanque R. Ehlers–Danlos Syndrome Type Arthrochalasia: A Systematic Review. Int. J. Environ. Res. Public Health. 2022;19:1870. doi: 10.3390/ijerph19031870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Demmler J.C., Atkinson M.D., Reinhold E.J., Choy E., Lyons R.A., Brophy S.T. Diagnosed Prevalence of Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorder in Wales, UK: A National Electronic Cohort Study and Case–Control Comparison. BMJ Open. 2019;9:e031365. doi: 10.1136/bmjopen-2019-031365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Daylor V., Griggs M., Weintraub A., Byrd R., Petrucci T., Huff M., Byerly K., Fenner R., Severance S., Griggs C., et al. Defining the Chronic Complexities of hEDS and HSD: A Global Survey of Diagnostic Challenges, Life-Long Comorbidities, and Unmet Needs. J. Clin. Med. 2025;14:5636. doi: 10.3390/jcm14165636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Glayzer J.E., Bray B.C., Kobak W.H., Steffen A.D., Schlaeger J.M. Lack of Diversity in Research on Females with Ehlers–Danlos Syndromes: Recruitment Protocol for a Quantitative Online Survey. JMIR Res. Protoc. 2024;13:e53646. doi: 10.2196/53646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yen J.-L., Lin S.-P., Chen M.-R., Niu D.-M. Clinical Features of Ehlers–Danlos Syndrome. J. Formos. Med. Assoc. 2006;105:475–480. doi: 10.1016/S0929-6646(09)60187-X. [DOI] [PubMed] [Google Scholar]
  • 6.Murray B., Yashar B.M., Uhlmann W.R., Clauw D.J., Petty E.M. Ehlers–Danlos Syndrome, Hypermobility Type: A Characterization of the Patients’ Lived Experience. Am. J. Med. Genet. Part A. 2013;161:2981–2988. doi: 10.1002/ajmg.a.36293. [DOI] [PubMed] [Google Scholar]
  • 7.Ritelli M., Chiarelli N., Cinquina V., Vezzoli M., Venturini M., Colombi M. Looking Back and beyond the 2017 Diagnostic Criteria for Hypermobile Ehlers–Danlos Syndrome: A Retrospective Cross-sectional Study from an Italian Reference Center. Am. J. Med. Genet. Part A. 2024;194:174–194. doi: 10.1002/ajmg.a.63426. [DOI] [PubMed] [Google Scholar]
  • 8.Gensemer C., Burks R., Kautz S., Judge D.P., Lavallee M., Norris R.A. Hypermobile Ehlers–Danlos Syndromes: Complex Phenotypes, Challenging Diagnoses, and Poorly Understood Causes. Dev. Dyn. 2021;250:318–344. doi: 10.1002/dvdy.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jasemi A., Lauridsen E.F., Sonnesen L. Head Posture and Upper Spine Morphological Deviations in Patients with Hypermobile Ehlers–Danlos Syndrome. Orthod. Craniofac. Res. 2025;28:555–563. doi: 10.1111/ocr.12907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chalela S., Russek L.N. Presentation and Physical Therapy Management Using a Neuroplasticity Approach for Patients with Hypermobility-Related Upper Cervical Instability: A Brief Report. Front. Neurol. 2024;15:1459115. doi: 10.3389/fneur.2024.1459115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kozyra M., Kostyun R., Strecker S. The Prevalence of Multisystem Diagnoses among Young Patients with Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorder: A Retrospective Analysis Using a Large Healthcare Claims Database. Medicine. 2024;103:e39212. doi: 10.1097/MD.0000000000039212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Thwaites P.A., Gibson P.R., Burgell R.E. Hypermobile Ehlers–Danlos Syndrome and Disorders of the Gastrointestinal Tract: What the Gastroenterologist Needs to Know. J. Gastroenterol. Hepatol. 2022;37:1693–1709. doi: 10.1111/jgh.15927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zeitoun J.-D., Lefèvre J.H., De Parades V., Séjourné C., Sobhani I., Coffin B., Hamonet C. Functional Digestive Symptoms and Quality of Life in Patients with Ehlers–Danlos Syndromes: Results of a National Cohort Study on 134 Patients. PLoS ONE. 2013;8:e80321. doi: 10.1371/journal.pone.0080321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Eichinger J.K., Byrd R.L., Bailey E.P., Reis R.J., Daylor V., Schiessl M., Gensemer C., Friedman R.J., Patel S.J., Norris R.A. Orthopaedic Manifestations in Hypermobile Ehlers–Danlos Syndrome. J. Bone Jt. Surg. 2025;107:1848–1856. doi: 10.2106/JBJS.24.01106. [DOI] [PubMed] [Google Scholar]
  • 15.Stein T., Collins S., St Louis J. The Prevalence of Hypermobile Ehlers–Danlos Syndrome at a Gender-Affirming Primary Care Clinic. Sage Open Med. 2025;13:20503121251315021. doi: 10.1177/20503121251315021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Malfait F., Castori M., Francomano C.A., Giunta C., Kosho T., Byers P.H. The Ehlers–Danlos Syndromes. Nat. Rev. Dis. Primer. 2020;6:64. doi: 10.1038/s41572-020-0194-9. [DOI] [PubMed] [Google Scholar]
  • 17.Song B., Yeh P., Harrell J. Systemic Manifestations of Ehlers–Danlos Syndrome. Bayl. Univ. Med. Cent. Proc. 2021;34:49–53. doi: 10.1080/08998280.2020.1805714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Anderson L.K., Lane K.R. Clinical Trajectory of Hypermobile Ehlers–Danlos Syndrome/Hypermobility Spectrum Disorders in Older Adults. J. Am. Assoc. Nurse Pract. 2023;35:605–612. doi: 10.1097/JXX.0000000000000900. [DOI] [PubMed] [Google Scholar]
  • 19.Grahame R. The Multisystemic Nature and Natural History of Joint Hypermobility Syndrome and Ehlers–Danlos Syndrome in Children. Rheumatology. 2017;56:2048–2049. doi: 10.1093/rheumatology/kex241. [DOI] [PubMed] [Google Scholar]
  • 20.Tinkle B., Castori M., Berglund B., Cohen H., Grahame R., Kazkaz H., Levy H. Hypermobile Ehlers–Danlos Syndrome (a.k.a. Ehlers–Danlos Syndrome Type III and Ehlers–Danlos Syndrome Hypermobility Type): Clinical Description and Natural History. Am. J. Med. Genet. Part C Semin. Med. Genet. 2017;175:48–69. doi: 10.1002/ajmg.c.31538. [DOI] [PubMed] [Google Scholar]
  • 21.Sinibaldi L., Ursini G., Castori M. Psychopathological Manifestations of Joint Hypermobility and Joint Hypermobility Syndrome/Ehlers–Danlos Syndrome, Hypermobility Type: The Link between Connective Tissue and Psychological Distress Revised. Am. J. Med. Genet. Part C Semin. Med. Genet. 2015;169:97–106. doi: 10.1002/ajmg.c.31430. [DOI] [PubMed] [Google Scholar]
  • 22.Song J.Z., Luong D., Feldman E.C.H., Tran S., Perrier L., Eubanks K., Bayley M., Kastner M., Slepian M., Munce S.E.P. Psychological Interventions for Individuals with Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorder: A Scoping Review. Orphanet J. Rare Dis. 2023;18:254. doi: 10.1186/s13023-023-02799-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pezaro S., Brock I., Buckley M., Callaway S., Demirdas S., Hakim A., Harris C., High Gross C., Karanfil M., Le Ray I., et al. Management of Childbearing with Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders: A Scoping Review and Expert Co-Creation of Evidence-Based Clinical Guidelines. PLoS ONE. 2024;19:e0302401. doi: 10.1371/journal.pone.0302401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ruiz Maya T., Fettig V., Mehta L., Gelb B.D., Kontorovich A.R. Dysautonomia in Hypermobile Ehlers–Danlos Syndrome and Hypermobility Spectrum Disorders Is Associated with Exercise Intolerance and Cardiac Atrophy. Am. J. Med. Genet. Part A. 2021;185:3754–3761. doi: 10.1002/ajmg.a.62446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Novak P., Systrom D.M., Marciano S.P., Witte A., Warren A., Felsenstein D., Giannetti M.P., Hamilton M.J., Nicoloro-SantaBarbara J., Castells M., et al. Hypermobile Ehlers–Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features. Am. J. Med. Open. 2025;14:100111. doi: 10.1016/j.ajmo.2025.100111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Higo A., Palmer S., Liaghat B., Tallis J., Silvester L., Pearce G. The Effectiveness of Conservative Interventions on Pain, Function, and Quality of Life in Adults with Hypermobile Ehlers–Danlos Syndrome/Hypermobility Spectrum Disorders and Shoulder Symptoms: A Systematic Review. Arch. Rehabil. Res. Clin. Transl. 2024;6:100360. doi: 10.1016/j.arrct.2024.100360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Corrado B., Ciardi G. Hypermobile Ehlers–Danlos Syndrome and Rehabilitation: Taking Stock of Evidence Based Medicine: A Systematic Review of the Literature. J. Phys. Ther. Sci. 2018;30:843–847. doi: 10.1589/jpts.30.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Xu K., Li G., Zhang T.J., Wu N. Shaping the Future of Care for Patients with Ehlers–Danlos Syndromes: From Multidisciplinary Management to Precision Medicine. Orphanet J. Rare Dis. 2025;20:98. doi: 10.1186/s13023-025-03615-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hauser R.A., Griffiths M., Matias D., Rawlings B.R. Cervical Oculopathy: The Cervical Spine Etiology of Visual Symptoms and Eye Diseases—A Hypothesis Exploring Mechanisms Linking the Neck and the Eye. Diagnostics. 2025;15:2650. doi: 10.3390/diagnostics15202650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Freeman M.D., Katz E.A., Rosa S.L., Gatterman B.G., Strömmer E.M.F., Leith W.M. Diagnostic Accuracy of Videofluoroscopy for Symptomatic Cervical Spine Injury Following Whiplash Trauma. Int. J. Env. Res. Public Health. 2020;17:1693. doi: 10.3390/ijerph17051693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hinck V.C., Hopkins C.E. Measurement of the Atlanto-Dental Interval in the Adult. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1960;84:945–951. [PubMed] [Google Scholar]
  • 32.Hauser R.A., Matias D., Rawlings B. The Ligamentous Cervical Instability Etiology of Human Disease from the Forward Head-Facedown Lifestyle: Emphasis on Obstruction of Fluid Flow into and out of the Brain. Front. Neurol. 2024;15:1430390. doi: 10.3389/fneur.2024.1430390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Daffner R. Imaging of Vertebral Trauma. 3rd ed. Cambridge University Press; Cambridge, UK: 2011. [Google Scholar]
  • 34.Alvarez A.P., Anderson A., Farhan S.-D., Lu Y., Lee Y.-P., Oh M., Rosen C., Kiester D., Bhatia N. The Utility of Flexion-Extension Radiographs in Degenerative Cervical Spondylolisthesis. Clin. Spine Surg. 2022;35:319–322. doi: 10.1097/BSD.0000000000001307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Borden A.G.B., Rechtman A.M., Gershon-Cohen J. The Normal Cervical Lordosis. Radiology. 1960;74:806–809. doi: 10.1148/74.5.806. [DOI] [PubMed] [Google Scholar]
  • 36.Hou S.B., Sun X.Z., Liu F.Y. Relationship of Change in Cervical Curvature after Laminectomy with Lateral Mass Screw Fixation to Spinal Cord Shift and Clinical Efficacy. J. Neurol. Surg. Cent. Eur. Neurosurg. 2022;83:129–134. doi: 10.1055/s-0041-1723807. [DOI] [PubMed] [Google Scholar]
  • 37.Abdelnaby R., Elsayed M., Mohamed K.A., Dardeer K.T., Sonbol Y.T., ELgenidy A., Barakat M.H., NasrEldin Y.K., Maier A. Sonographic Reference Values of Vagus Nerve: A Systematic Review and Meta-Analysis. J. Clin. Neurophysiol. 2022;39:59–71. doi: 10.1097/WNP.0000000000000856. [DOI] [PubMed] [Google Scholar]
  • 38.Trollip L., Alberto K., Makgotloe A. Optic Nerve Sheath Diameter: A Cross-Sectional Study of Ultrasonographic Measurement in Healthy Black South African Adults. Life. 2023;13:1979. doi: 10.3390/life13101979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Spector R. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Butterworth Publishers; Boston, MA, USA: 1990. [PubMed] [Google Scholar]
  • 40.Steinhauer S.R., Bradley M.M., Siegle G.J., Roecklein K.A., Dix A. Publication Guidelines and Recommendations for Pupillary Measurement in Psychophysiological Studies. Psychophysiology. 2022;59:e14035. doi: 10.1111/psyp.14035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Huckemann S., Mueller K., Averdunk P., Kühn E., Hilker L., Kools S., Scholz L., Bulut Y., Brünger J., Fiegert S., et al. Vagal Cross-Sectional Area Correlates with Parasympathetic Dysfunction in Parkinson’s Disease. Brain Commun. 2022;5:fcad006. doi: 10.1093/braincomms/fcad006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bedewi M.A., Kotb M.A., Almalki D.M., AlAseeri A.A., Sandougah K.J., Abdelnaby R., Soliman S.B., Alhariqi B.A., Alfaifi T., Aldossary N.M. Ultrasound of the Normal Vagus Nerve Cross-Sectional Area in the Carotid Sheath. Medicine. 2023;102:e33996. doi: 10.1097/MD.0000000000033996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Aljure O., Castillo-Pedraza C.M., Mitzova-Vladinov G., Maratea E.A. Right Internal Jugular Vein Cross-Sectional Area: Is There an Optimal Level for Cannulation? J. Assoc. Vasc. Access. 2015;20:22–25. doi: 10.1016/j.java.2014.11.002. [DOI] [Google Scholar]
  • 44.Yoon H.-K., Lee H.-K., Jeon Y.-T., Hwang J.-W., Lim S.-M., Park H.-P. Clinical Significance of the Cross-Sectional Area of the Internal Jugular Vein. J. Cardiothorac. Vasc. Anesth. 2013;27:685–689. doi: 10.1053/j.jvca.2012.10.007. [DOI] [PubMed] [Google Scholar]
  • 45.Tartière D., Seguin P., Juhel C., Laviolle B., Mallédant Y. Estimation of the Diameter and Cross-Sectional Area of the Internal Jugular Veins in Adult Patients. Crit. Care. 2009;13:R197. doi: 10.1186/cc8200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bovenzi M., Welsh A.J.L., Della Vedova A., Griffin M.J. Acute Effects of Force and Vibration on Finger Blood Flow. Occup. Environ. Med. 2006;63:84–91. doi: 10.1136/oem.2004.019703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Nelson J., Patel D., Sant H.J., Shea J., Gale B.K., Agarwal J. Compression of the Vascular Wall to Create a Friction Fit in a Vascular Anastomotic Coupler. J. Mech. Behav. Biomed. Mater. 2021;123:104681. doi: 10.1016/j.jmbbm.2021.104681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Stecker M., Baylor K., Chan Y. Acute Nerve Compression and the Compound Muscle Action Potential. J. Brachial Plex. Peripher. Nerve Inj. 2014;3:e5–e13. doi: 10.1186/1749-7221-3-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.National Research Council. Board on Human-Systems Integration. Steering Committee for the Workshop on Work-Related Musculoskeletal Injuries and The Research Base . Work-Related Musculoskeletal Disorders: Report, Workshop Summary, and Workshop Papers. National Academies Press; Washington, DC, USA: 1999. p. 6431. [Google Scholar]
  • 50.Chayapinun V., Koratala A., Assavapokee T. Seeing beneath the Surface: Harnessing Point-of-Care Ultrasound for Internal Jugular Vein Evaluation. World J. Cardiol. 2024;16:73–79. doi: 10.4330/wjc.v16.i2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kim S.B., Shaia J.K., Kaelber D.C., Singh R.P., Talcott K.E. Ocular Manifestations in Ehlers–Danlos Syndrome. Eye. 2025;39:1990–1997. doi: 10.1038/s41433-025-03787-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Alim-Marvasti A., Ciocca M., Kuleindiren N., Lin A., Selim H., Mahmud M. Subjective Brain Fog: A Four-Dimensional Characterization in 25,796 Participants. Front. Hum. Neurosci. 2024;18:1409250. doi: 10.3389/fnhum.2024.1409250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yoon J.-H., Park N.-H., Kang Y.-E., Ahn Y.-C., Lee E.-J., Son C.-G. The Demographic Features of Fatigue in the General Population Worldwide: A Systematic Review and Meta-Analysis. Front. Public Health. 2023;11:1192121. doi: 10.3389/fpubh.2023.1192121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Scher A.I., Stewart W.F., Liberman J., Lipton R.B. Prevalence of Frequent Headache in a Population Sample. Headache J. Head Face Pain. 1998;38:497–506. doi: 10.1046/j.1526-4610.1998.3807497.x. [DOI] [PubMed] [Google Scholar]
  • 55.Centers for Disease Control and Prevention Disability Impacts All of Us Infographic. [(accessed on 17 December 2025)]; Available online: https://www.cdc.gov/disability-and-health/articles-documents/disability-impacts-all-of-us-infographic.html.
  • 56.Global Burden of Neck Pain in 204 Countries from 1990–2019. [(accessed on 14 August 2025)]. Available online: https://www.archivesofmedicalscience.com/Global-burden-of-neck-pain-in-204-countries-from-1990-2019,170962,0,2.html.
  • 57.Malhotra A., Pace A., Ruiz Maya T., Colman R., Gelb B.D., Mehta L., Kontorovich A.R. Headaches in Hypermobility Syndromes: A Pain in the Neck? Am. J. Med. Genet. Part A. 2020;182:2902–2908. doi: 10.1002/ajmg.a.61873. [DOI] [PubMed] [Google Scholar]
  • 58.Woo M.S., Shafiq M., Fitzek A., Dottermusch M., Altmeppen H., Mohammadi B., Mayer C., Bal L.C., Raich L., Matschke J., et al. Vagus Nerve Inflammation Contributes to Dysautonomia in COVID-19. Acta Neuropathol. 2023;146:387–394. doi: 10.1007/s00401-023-02612-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Zou N., Zhou Q., Zhang Y., Xin C., Wang Y., Claire-Marie R., Rong P., Gao G., Li S. Transcutaneous Auricular Vagus Nerve Stimulation as a Novel Therapy Connecting the Central and Peripheral Systems: A Review. Int. J. Surg. 2024;110:4993–5006. doi: 10.1097/JS9.0000000000001592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Courties A., Berenbaum F., Sellam J. Vagus Nerve Stimulation in Musculoskeletal Diseases. Jt. Bone Spine. 2021;88:105149. doi: 10.1016/j.jbspin.2021.105149. [DOI] [PubMed] [Google Scholar]
  • 61.Alauddin W., Alam S., Mishra M., Radke P.M., Shree R., Prajesh B.R., Chaturvedi A., Patil A., Singh T.K., Ahmad M.F. A Cross-Sectional Study of Cardiovascular Autonomic Reactivity in Ehlers–Danlos Syndrome. Cureus. 2024;16:e64542. doi: 10.7759/cureus.64542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Westerman M., Kafkas A., Parry-Jones A., Strong S., Retzler C., Hallam G. Neurobiological and Neuropsychological Disturbance in EDS. Front. Neurol. 2025;16:1648702. doi: 10.3389/fneur.2025.1648702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Chakraborty P., Farhat K., Morris L., Whyte S., Yu X., Stavrakis S. Non-Invasive Vagus Nerve Simulation in Postural Orthostatic Tachycardia Syndrome. Arrhythmia Electrophysiol. Rev. 2023;12:e31. doi: 10.15420/aer.2023.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Henderson F.C., Austin C., Benzel E., Bolognese P., Ellenbogen R., Francomano C.A., Ireton C., Klinge P., Koby M., Long D., et al. Neurological and Spinal Manifestations of the Ehlers–Danlos Syndromes. Am. J. Med. Genet. C Semin. Med. Genet. 2017;175:195–211. doi: 10.1002/ajmg.c.31549. [DOI] [PubMed] [Google Scholar]
  • 65.Severance S., Daylor V., Petrucci T., Gensemer C., Patel S., Norris R.A. Hypermobile Ehlers–Danlos Syndrome and Spontaneous CSF Leaks: The Connective Tissue Conundrum. Front. Neurol. 2024;15:1452409. doi: 10.3389/fneur.2024.1452409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.De Wandele I., Rombaut L., Leybaert L., Van De Borne P., De Backer T., Malfait F., De Paepe A., Calders P. Dysautonomia and Its Underlying Mechanisms in the Hypermobility Type of Ehlers–Danlos Syndrome. Semin. Arthritis Rheum. 2014;44:93–100. doi: 10.1016/j.semarthrit.2013.12.006. [DOI] [PubMed] [Google Scholar]
  • 67.Kucharik A.H., Chang C. The Relationship Between Hypermobile Ehlers–Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS) Clin. Rev. Allergy Immunol. 2020;58:273–297. doi: 10.1007/s12016-019-08755-8. [DOI] [PubMed] [Google Scholar]
  • 68.Beighton P.H., Grahame R., Bird H. Hypermobility of Joints. Springer-Verlag London Limited; London, UK: 2012. [Google Scholar]
  • 69.Wang T.J., Stecco A., Hakim A.J., Schleip R. Fascial Pathophysiology in Hypermobility Spectrum Disorders and Hypermobile Ehlers–Danlos Syndrome: A Review of Emerging Evidence. Int. J. Mol. Sci. 2025;26:5587. doi: 10.3390/ijms26125587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Uehara M., Kosho T., Yamamoto N., Takahashi H.E., Shimakura T., Nakayama J., Kato H., Takahashi J. Spinal Manifestations in 12 Patients with Musculocontractural Ehlers–Danlos Syndrome Caused by CHST14/D4ST1 Deficiency (mcEDS-CHST14) Am. J. Med. Genet. Part A. 2018;176:2331–2341. doi: 10.1002/ajmg.a.40507. [DOI] [PubMed] [Google Scholar]
  • 71.Henderson F.C., Schubart J.R., Narayanan M.V., Tuchman K., Mills S.E., Poppe D.J., Koby M.B., Rowe P.C., Francomano C.A. Craniocervical Instability in Patients with Ehlers–Danlos Syndromes: Outcomes Analysis Following Occipito-Cervical Fusion. Neurosurg. Rev. 2024;47:27. doi: 10.1007/s10143-023-02249-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Smith F.W., Dworkin J., editors. The Craniocervical Syndrome and MRI. Karger; Basel, Switzerland: 2015. [Google Scholar]
  • 73.Michel C., Dijanic C., Abdelmalek G., Sudah S., Kerrigan D., Yalamanchili P. Upper Cervical Spine Instability Systematic Review: A Bibliometric Analysis of the 100 Most Influential Publications. J. Spine Surg. 2022;8:266–275. doi: 10.21037/jss-21-132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Steilen D., Hauser R., Woldin B., Sawyer S. Chronic Neck Pain: Making the Connection between Capsular Ligament Laxity and Cervical Instability. Open Orthop. J. 2014;8:326–345. doi: 10.2174/1874325001408010326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Goel A. A Review of a New Clinical Entity of ‘Central Atlantoaxial Instability’: Expanding Horizons of Craniovertebral Junction Surgery. Neurospine. 2019;16:186–194. doi: 10.14245/ns.1938138.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Skalski M., Bell D., Sharma R. Lateral Atlantodental Instability. Radiopaedia.org; Cotham, Australia: 2021. [Google Scholar]
  • 77.Hauser R.A., Steilen D., Gordin K. The Biology of Prolotherapy and Its Application in Clinical Cervical Spine Instability and Chronic Neck Pain: A Retrospective Study. Eur. J. Prev. Med. 2015;3:85–102. doi: 10.11648/j.ejpm.20150304.11. [DOI] [Google Scholar]
  • 78.Yang S.Y., Boniello A.J., Poorman C.E., Chang A.L., Wang S., Passias P.G. A Review of the Diagnosis and Treatment of Atlantoaxial Dislocations. Glob. Spine J. 2014;4:197–210. doi: 10.1055/s-0034-1376371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Mao G., Kopparapu S., Jin Y., Davidar A.D., Hersh A.M., Weber-Levine C., Theodore N. Craniocervical Instability in Patients with Ehlers–Danlos Syndrome: Controversies in Diagnosis and Management. Spine J. 2022;22:1944–1952. doi: 10.1016/j.spinee.2022.08.008. [DOI] [PubMed] [Google Scholar]
  • 80.Sheng X., Deng Y., Huang C., Pan N., Zhao Y., Gong Q., Gong Q., Song Y., Liu H., Meng Y. Novel MRI Signs in Atlantodental Space Predict Reduction Degree of Atlantoaxial Dislocation. Orthop. Surg. 2025;17:163–171. doi: 10.1111/os.14281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Lacy J., Bajaj J., Christopher C. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023. Gillis Atlantoaxial Instability. [PubMed] [Google Scholar]
  • 82.Castori M. Ehlers–Danlos Syndrome, Hypermobility Type: An Underdiagnosed Hereditary Connective Tissue Disorder with Mucocutaneous, Articular, and Systemic Manifestations. ISRN Dermatol. 2012;2012:751768. doi: 10.5402/2012/751768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Marathe N., Lohkamp L.-N., Fehlings M.G. Spinal Manifestations of Ehlers–Danlos Syndrome: A Scoping Review. J. Neurosurg. Spine. 2022;37:783–793. doi: 10.3171/2022.6.SPINE211011. [DOI] [PubMed] [Google Scholar]
  • 84.Knopp R., Parker J., Tashjian J., Ganz W. Defining Radiographic Criteria for Flexion-Extension Studies of the Cervical Spine. Ann. Emerg. Med. 2001;38:31–35. doi: 10.1067/mem.2001.114319. [DOI] [PubMed] [Google Scholar]
  • 85.Russek L.N., Block N.P., Byrne E., Chalela S., Chan C., Comerford M., Frost N., Hennessey S., McCarthy A., Nicholson L.L., et al. Presentation and Physical Therapy Management of Upper Cervical Instability in Patients with Symptomatic Generalized Joint Hypermobility: International Expert Consensus Recommendations. Front. Med. 2023;9:1072764. doi: 10.3389/fmed.2022.1072764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Bascom R., Dhingra R., Francomano C.A. Respiratory Manifestations in the Ehlers–Danlos Syndromes. Am. J. Med. Genet. Part C Semin. Med. Genet. 2021;187:533–548. doi: 10.1002/ajmg.c.31953. [DOI] [PubMed] [Google Scholar]
  • 87.Syx D., De Wandele I., Rombaut L., Malfait F. Hypermobility, the Ehlers–Danlos Syndromes and Chronic Pain. Clin. Exp. Rheumatol. 2017;35:116–122. [PubMed] [Google Scholar]
  • 88.Hülse M. Differential diagnosis of vertigo in functional cervical vertebrae joint syndromes and vertebrobasilar insufficiency. HNO. 1982;30:440–446. [PubMed] [Google Scholar]
  • 89.Sung Y.-H. Upper Cervical Spine Dysfunction and Dizziness. J. Exerc. Rehabil. 2020;16:385–391. doi: 10.12965/jer.2040612.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Alsiri N., Palmer S. Biomechanical Changes in the Gastrocnemius Medius–Achilles Tendon Complex in People with Hypermobility Spectrum Disorders: A Cross-Sectional Compression Sonoelastography Study. Front. Med. 2023;10:1062808. doi: 10.3389/fmed.2023.1062808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Chu E.P., Lo F., Bhaumik A. Plausible Impact of Forward Head Posture on Upper Cervical Spine Stability. J. Fam. Med. Prim. Care. 2020;9:2517. doi: 10.4103/jfmpc.jfmpc_95_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Hansraj K.K. Assessment of Stresses in the Cervical Spine Caused by Posture and Position of the Head. Surg. Technol. Int. 2014;25:277–279. [PubMed] [Google Scholar]
  • 93.Lee S., Kang H., Shin G. Head Flexion Angle While Using a Smartphone. Ergonomics. 2015;58:220–226. doi: 10.1080/00140139.2014.967311. [DOI] [PubMed] [Google Scholar]
  • 94.Gensemer C., Daylor V., Nix J., Norris R.A., Patel S. Co-Occurrence of Tethered Cord Syndrome and Cervical Spine Instability in Hypermobile Ehlers–Danlos Syndrome. Front. Neurol. 2024;15:1441866. doi: 10.3389/fneur.2024.1441866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Katz E.A., Katz S.B., Freeman M.D. Non-Surgical Management of Upper Cervical Instability via Improved Cervical Lordosis: A Case Series of Adult Patients. J. Clin. Med. 2023;12:1797. doi: 10.3390/jcm12051797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Ding J., Zhou D., Pan L., Ya J., Liu C., Yan F., Fan C., Ding Y., Ji X., Meng R. Cervical Spondylotic Internal Jugular Venous Compression Syndrome. CNS Neurosci. Ther. 2019;26:47–54. doi: 10.1111/cns.13148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Dincă V., Ionescu P., Tudose R.C., Munteanu M., Vrapciu A.D., Rusu M.C. Anatomical Reasons for an Impaired Internal Jugular Flow. Medicina. 2025;61:1627. doi: 10.3390/medicina61091627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Petersingham G., Shrestha N., Elliott M., Allan R.S., Parker G., Camp L.V., Rao P.J. Invasive Surgical Management of Cervical Internal Jugular Venous Compression: A Literature Review. J. Clin. Neurosci. 2025;137:111304. doi: 10.1016/j.jocn.2025.111304. [DOI] [PubMed] [Google Scholar]
  • 99.Lan D., Song S., Jia M., Wang M., Jiao B., Liu Y., Ding Y., Ji X., Meng R. Cerebral Venous-Associated Brain Damage May Lead to Anxiety and Depression. J. Clin. Med. 2022;11:6927. doi: 10.3390/jcm11236927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Zhou D., Ding J.Y., Ya J.Y. Understanding jugular venous outflow disturbance. CNS Neurosci. Ther. 2018;24:473–482. doi: 10.1111/cns.12859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Zamboni P., Menegatti E., Weinstock-Guttman B., Dwyer M.G., Schirda C.V., Malagoni A.M., Hojnacki D., Kennedy C., Carl E., Bergsland N., et al. Hypoperfusion of Brain Parenchyma Is Associated with the Severity of Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis: A Cross-Sectional Preliminary Report. BMC Med. 2011;9:22. doi: 10.1186/1741-7015-9-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Beggs C.B. Venous Hemodynamics in Neurological Disorders: An Analytical Review with Hydrodynamic Analysis. BMC Med. 2013;11:142. doi: 10.1186/1741-7015-11-142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Schaller B., Graf R. Cerebral Venous Infarction: The Pathophysiological Concept. Cerebrovasc. Dis. 2004;18:179–188. doi: 10.1159/000079939. [DOI] [PubMed] [Google Scholar]
  • 104.Kawalec-Rutkowska A.M., Czaja J., Skuła M., Simka M. Blood Flow in the Internal Jugular Veins in the Lateral Decubitus Body Position in the Healthy People. J. Clin. Med. 2025;14:1211. doi: 10.3390/jcm14041211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Khawari S., Al-Mohammad A., Pandit A., Moncur E., Bancroft M.J., Tariq K., Cowley P., Watkins L., Toma A. ICP during Head Movement: Significance of the Venous System. Acta Neurochir. 2023;165:3243–3247. doi: 10.1007/s00701-023-05620-8. [DOI] [PubMed] [Google Scholar]
  • 106.Soldatos T., Karakitsos D., Chatzimichail K., Papathanasiou M., Gouliamos A., Karabinis A. Optic Nerve Sonography in the Diagnostic Evaluation of Adult Brain Injury. Crit. Care. 2008;12:R67. doi: 10.1186/cc6897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Kimberly H.H., Shah S., Marill K., Noble V. Correlation of Optic Nerve Sheath Diameter with Direct Measurement of Intracranial Pressure. Acad. Emerg. Med. 2008;15:201–204. doi: 10.1111/j.1553-2712.2007.00031.x. [DOI] [PubMed] [Google Scholar]
  • 108.Berhanu D., Ferreira J.C., Abegão Pinto L., Aguiar de Sousa D., Lucas Neto L., Tavares Ferreira J. The Role of Optic Nerve Sheath Ultrasonography in Increased Intracranial Pressure: A Systematic Review and Meta Analysis. J. Neurol. Sci. 2023;454:120853. doi: 10.1016/j.jns.2023.120853. [DOI] [PubMed] [Google Scholar]
  • 109.Maissan I.M., Dirven P.J.A.C., Haitsma I.K., Hoeks S.E., Gommers D., Stolker R.J. Ultrasonographic Measured Optic Nerve Sheath Diameter as an Accurate and Quick Monitor for Changes in Intracranial Pressure. J. Neurosurg. 2015;123:743–747. doi: 10.3171/2014.10.JNS141197. [DOI] [PubMed] [Google Scholar]
  • 110.Jalayondeja T., Urasyanandana K. Correlations between Optic Nerve Sheath Diameters Measured Using Computed Tomography and Elevated Intracranial Pressure Levels. Interdiscip. Neurosurg. 2021;26:101328. doi: 10.1016/j.inat.2021.101328. [DOI] [Google Scholar]
  • 111.Ussahgij W., Toonpirom W., Munkong W., Lenghong K., Apiratwarakul K. Optic Nerve Sheath Diameter Cutoff Point for Detection of Increased Intracranial Pressure in the Emergency Department. Open Access Maced. J. Med. Sci. 2020;8:62–65. doi: 10.3889/oamjms.2020.3272. [DOI] [Google Scholar]
  • 112.Yic C.D., Pontet J., Mercado M., Muñoz M., Biestro A. Ultrasonographic Measurement of the Optic Nerve Sheath Diameter to Detect Intracranial Hypertension: An Observational Study. Ultrasound J. 2023;15:4. doi: 10.1186/s13089-022-00304-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Fargen K.M., Midtlien J.P., Margraf C.R., Hui F.K. Idiopathic intracranial hypertension pathogenesis: The jugular hypothesis. Interv. Neuroradiol. 2024;8:15910199241270660. doi: 10.1177/15910199241270660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Higgins J.N.P., Borchert R.J., Rao S., Biddle D.J., Santarius T., Joannides A.J. Cranial Venous Outflow Insufficiency; Rendered Almost Invisible to Radiological Imaging by Circular Reasoning. Rethinking Normal Craniocervical Venous Anatomy. J. Clin. Neurosci. 2024;130:110882. doi: 10.1016/j.jocn.2024.110882. [DOI] [PubMed] [Google Scholar]
  • 115.Doppler Ultrasonography—An Overview|ScienceDirect Topics. [(accessed on 24 February 2026)]. Available online: https://www.sciencedirect.com/topics/nursing-and-health-professions/doppler-ultrasonography.
  • 116.Van Zandwijk J.K., Kuijer K.M., Stassen C.M., Ten Haken B., Simonis F.F.J. Internal Jugular Vein Geometry Under Multiple Inclination Angles with 3D Low-Field MRI in Healthy Volunteers. J. Magn. Reson. Imaging. 2022;56:1302–1308. doi: 10.1002/jmri.28182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Suwaidi A.S.A., Moustafa I.M., Kim M., Oakley P.A., Harrison D.E. A Comparison of Two Forward Head Posture Corrective Approaches in Elderly with Chronic Non-Specific Neck Pain: A Randomized Controlled Study. J. Clin. Med. 2023;12:542. doi: 10.3390/jcm12020542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Fortner M.O., Oakley P.A., Harrison D.E. Alleviation of Chronic Spine Pain and Headaches by Reducing Forward Head Posture and Thoracic Hyperkyphosis: A CBP® Case Report. J. Phys. Ther. Sci. 2018;30:1117–1123. doi: 10.1589/jpts.30.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Moustafa I.M., Diab A.A., Hegazy F., Harrison D.E. Does Improvement towards a Normal Cervical Sagittal Configuration Aid in the Management of Cervical Myofascial Pain Syndrome: A 1- Year Randomized Controlled Trial. BMC Musculoskelet. Disord. 2018;19:396. doi: 10.1186/s12891-018-2317-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Midtlien J.P., Curry B.P., Chang E., Kiritsis N.R., Aldridge J.B., Fargen K.M. Characterizing a New Clinical Phenotype: The Co-Existence of Cerebral Venous Outflow and Connective Tissue Disorders. Front. Neurol. 2024;14:1305972. doi: 10.3389/fneur.2023.1305972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Li M., Sun Y., Chan C.C., Fan C., Ji X., Meng R. Internal Jugular Vein Stenosis Associated with Elongated Styloid Process: Five Case Reports and Literature Review. BMC Neurol. 2019;19:112. doi: 10.1186/s12883-019-1344-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Jayaraman M.V., Boxerman J.L., Davis L.M., Haas R.A., Rogg J.M. Incidence of Extrinsic Compression of the Internal Jugular Vein in Unselected Patients Undergoing CT Angiography. Am. J. Neuroradiol. 2012;33:1247–1250. doi: 10.3174/ajnr.A2953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Eide P.K., Pripp A.H., Ringstad G., Valnes L.M. Impaired Glymphatic Function in Idiopathic Intracranial Hypertension. Brain Commun. 2021;3:fcab043. doi: 10.1093/braincomms/fcab043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Tuță S. Cerebral Venous Outflow Implications in Idiopathic Intracranial Hypertension—From Physiopathology to Treatment. Life. 2022;12:854. doi: 10.3390/life12060854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Primiani C.T., Lawton M., Hillis A.E., Hui F.K. Pearls & Oy-Sters: Cerebral Venous Congestion Associated with Cognitive Decline Treated by Jugular Release. Neurology. 2022;99:577–580. doi: 10.1212/wnl.0000000000201037. [DOI] [PubMed] [Google Scholar]
  • 126.Bai C., Chen Z., Ding Y., Ji X., Yuan J., Meng R. Long-term Safety and Efficacy of Stenting on Correcting Internal Jugular Vein and Cerebral Venous Sinus Stenosis. Ann. Clin. Transl. Neurol. 2023;10:1305–1313. doi: 10.1002/acn3.51822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Zhou D., Meng R., Zhang X. Intracranial Hypertension Induced by Internal Jugular Vein Stenosis Can Be Resolved by Stenting. Eur. J. Neurol. 2018;25:365-e13. doi: 10.1111/ene.13512. [DOI] [PubMed] [Google Scholar]
  • 128.Zhao X., Cavallo C., Hlubek R.J., Mooney M.A., Belykh E., Gandhi S., Moreira L.B., Lei T., Albuquerque F.C., Preul M.C., et al. Styloidogenic Jugular Venous Compression Syndrome: Clinical Features and Case Series. Oper. Neurosurg. 2019;17:554–561. doi: 10.1093/ons/opz012. [DOI] [PubMed] [Google Scholar]
  • 129.Higgins J., Garnett M., Pickard J., Axon P. An Evaluation of Styloidectomy as an Adjunct or Alternative to Jugular Stenting in Idiopathic Intracranial Hypertension and Disturbances of Cranial Venous Outflow. J. Neurol. Surg. Part B Skull Base. 2016;78:158–163. doi: 10.1055/s-0036-1594238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Pedersen S.H., Andresen M., Lilja-Cyron A., Petersen L.G., Juhler M. Lumbar Puncture Position Influences Intracranial Pressure. Acta Neurochir. 2021;163:1997–2004. doi: 10.1007/s00701-021-04813-3. [DOI] [PubMed] [Google Scholar]
  • 131.Teng C., Gurses-Ozden R., Liebmann J.M., Tello C., Ritch R. Effect of a Tight Necktie on Intraocular Pressure. Br. J. Ophthalmol. 2003;87:946–948. doi: 10.1136/bjo.87.8.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Zhu Z., Waxman S., Wang B. Interplay between Intraocular and Intracranial Pressure Effects on the Optic Nerve Head In Vivo. Exp. Eye Res. 2021;213:108809. doi: 10.1016/j.exer.2021.108809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Li Z., Yang Y., Lu Y., Liu D., Xu E., Jia J., Yang D., Zhang X., Yang H., Ma D., et al. Intraocular Pressure vs. Intracranial Pressure in Disease Conditions: A Prospective Cohort Study (Beijing iCOP Study) BMC Neurol. 2012;12:66. doi: 10.1186/1471-2377-12-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Giovagnorio F., Martinoli C. Sonography of the Cervical Vagus Nerve: Normal Appearance and Abnormal Findings. AJR Am. J. Roentgenol. 2001;176:745–749. doi: 10.2214/ajr.176.3.1760745. [DOI] [PubMed] [Google Scholar]
  • 135.Chen H.-H., Chen T.-C., Yang T.-L., Wang C.-P. Transcutaneous Sonography for Detection of the Cervical Vagus Nerve. Ear. Nose. Throat J. 2021;100:155–159. doi: 10.1177/0145561319875432. [DOI] [PubMed] [Google Scholar]
  • 136.Breit S., Kupferberg A., Rogler G., Hasler G. Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders. Front. Psychiatry. 2018;9:44. doi: 10.3389/fpsyt.2018.00044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Agorastos A., Mansueto A.C., Hager T., Pappi E., Gardikioti A., Stiedl O. Heart Rate Variability as a Translational Dynamic Biomarker of Altered Autonomic Function in Health and Psychiatric Disease. Biomedicines. 2023;11:1591. doi: 10.3390/biomedicines11061591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Van Es V.A.A., De Lathauwer I.L.J., Kemps H.M.C., Handjaras G., Betta M. Remote Monitoring of Sympathovagal Imbalance During Sleep and Its Implications in Cardiovascular Risk Assessment: A Systematic Review. Bioengineering. 2024;11:1045. doi: 10.3390/bioengineering11101045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin. Nature. 2000;405:458–462. doi: 10.1038/35013070. [DOI] [PubMed] [Google Scholar]
  • 140.Ma L., Wang H.-B., Hashimoto K. The Vagus Nerve: An Old but New Player in Brain–Body Communication. Brain. Behav. Immun. 2025;124:28–39. doi: 10.1016/j.bbi.2024.11.023. [DOI] [PubMed] [Google Scholar]
  • 141.Pavlov V.A., Tracey K.J. The Vagus Nerve and the Inflammatory Reflex—Linking Immunity and Metabolism. Nat. Rev. Endocrinol. 2012;8:743–754. doi: 10.1038/nrendo.2012.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Fernandez A., Jaquet M., Aubry-Rozier B., Suter M., Aybek S., Berna C. Functional Neurological Signs in Hypermobile Ehlers–Danlos Syndrome and Hypermobile Spectrum Disorders with Suspected Neuropathic Pain. Brain Behav. 2024;14:e3441. doi: 10.1002/brb3.3441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Howland R.H. Vagus Nerve Stimulation. Curr. Behav. Neurosci. Rep. 2014;1:64–73. doi: 10.1007/s40473-014-0010-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Kupari J., Häring M., Agirre E., Castelo-Branco G., Ernfors P. An Atlas of Vagal Sensory Neurons and Their Molecular Specialization. Cell Rep. 2019;27:2508–2523.e4. doi: 10.1016/j.celrep.2019.04.096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Mavroudis I., Kazis D., Kamal F.Z., Gurzu I.-L., Ciobica A., Pădurariu M., Novac B., Iordache A. Understanding Functional Neurological Disorder: Recent Insights and Diagnostic Challenges. Int. J. Mol. Sci. 2024;25:4470. doi: 10.3390/ijms25084470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Lam C.Y., Palsson O.S., Whitehead W.E., Sperber A.D., Tornblom H., Simren M., Aziz I. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects with Hypermobility Spectrum Disorders or Hypermobile Ehlers–Danlos Syndrome. Clin. Gastroenterol. Hepatol. 2021;19:277–287.e3. doi: 10.1016/j.cgh.2020.02.034. [DOI] [PubMed] [Google Scholar]
  • 147.Fernandez A., Aubry-Rozier B., Vautey M., Berna C., Suter M.R. Small Fiber Neuropathy in Hypermobile Ehlers Danlos Syndrome/Hypermobility Spectrum Disorder. J. Intern. Med. 2022;292:957–960. doi: 10.1111/joim.13539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Cazzato D., Castori M., Lombardi R., Caravello F., Bella E.D., Petrucci A., Grammatico P., Dordoni C., Colombi M., Lauria G. Small Fiber Neuropathy Is a Common Feature of Ehlers–Danlos Syndromes. Neurology. 2016;87:155–159. doi: 10.1212/WNL.0000000000002847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Kersebaum D., Baron R., Gierthmühlen J., Forstenpointner J. Autonomic and Sensory Dysfunction in Hypermobile Ehlers–Danlos Syndrome: How Do Small Fibers Contribute? Auton. Neurosci. 2025;260:103306. doi: 10.1016/j.autneu.2025.103306. [DOI] [PubMed] [Google Scholar]
  • 150.Voermans N.C., Van Alfen N., Pillen S., Lammens M., Schalkwijk J., Zwarts M.J., Van Rooij I.A., Hamel B.C.J., Van Engelen B.G. Neuromuscular Involvement in Various Types of Ehlers–Danlos Syndrome. Ann. Neurol. 2009;65:687–697. doi: 10.1002/ana.21643. [DOI] [PubMed] [Google Scholar]
  • 151.Voermans N.C., Drost G., Kampen A., Gabreëls–Festen A.A., Lammens M., Hamel B.C., Schalkwijk J., Engelen B.G. Recurrent Neuropathy Associated with Ehlers–Danlos Syndrome. J. Neurol. 2006;253:670–671. doi: 10.1007/s00415-005-0056-0. [DOI] [PubMed] [Google Scholar]
  • 152.Baeza-Velasco C., Gely-Nargeot M.-C., Vilarrasa A.B., Fenetrier C., Bravo J.F. Association between Psychopathological Factors and Joint Hypermobility Syndrome in a Group of Undergraduates from a French University. Int. J. Psychiatry Med. 2011;41:187–201. doi: 10.2190/PM.41.2.g. [DOI] [PubMed] [Google Scholar]
  • 153.Eccles J.A., Beacher F.D.C., Gray M.A., Jones C.L., Minati L., Harrison N.A., Critchley H.D. Brain Structure and Joint Hypermobility: Relevance to the Expression of Psychiatric Symptoms. Br. J. Psychiatry. 2012;200:508–509. doi: 10.1192/bjp.bp.111.092460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Nagao S., Roccaforte P., Moody R.A. Acute Intracranial Hypertension and Auditory Brain-Stem Responses: Part 1: Changes in the Auditory Brain-Stem and Somatosensory Evoked Responses in Intracranial Hypertension in Cats. J. Neurosurg. 1979;51:669–676. doi: 10.3171/jns.1979.51.5.0669. [DOI] [PubMed] [Google Scholar]
  • 155.De Wandele I., Calders P., Peersman W., Rimbaut S., De Backer T., Malfait F., De Paepe A., Rombaut L. Autonomic Symptom Burden in the Hypermobility Type of Ehlers–Danlos Syndrome: A Comparative Study with Two Other EDS Types, Fibromyalgia, and Healthy Controls. Semin. Arthritis Rheum. 2014;44:353–361. doi: 10.1016/j.semarthrit.2014.05.013. [DOI] [PubMed] [Google Scholar]
  • 156.Goldberger J.J., Arora R., Buckley U., Shivkumar K. Autonomic Nervous System Dysfunction. J. Am. Coll. Cardiol. 2019;73:1189–1206. doi: 10.1016/j.jacc.2018.12.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Rydevik B., McLean W.G., Sjostrand J., Lundborg G. Blockage of Axonal Transport Induced by Acute, Graded Compression of the Rabbit Vagus Nerve. J. Neurol. Neurosurg. Psychiatry. 1980;43:690–698. doi: 10.1136/jnnp.43.8.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Hauser R.A., Matias D., Rawlings B.R. Cervicovagopathy: Ligamentous Cervical Instability and Dysstructure as a Potential Etiology for Vagus Nerve Dysfunction in the Cause of Human Symptoms and Diseases. Front. Neurol. 2025;16:1572863. doi: 10.3389/fneur.2025.1572863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.O’Dell J.A., Walker A., Latham A.J., Parisian D.J., Branch L.E., Vanderburg D.D., Cox A.A., Chavis S., Smith S.E. The Diagnostic Journey of Dysautonomia Patients: Insights from a Patient-Reported Outcome Study. J. Patient Exp. 2025;12:23743735251314651. doi: 10.1177/23743735251314651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Blitshteyn S. Dysautonomia: A Common Comorbidity of Systemic Disease. Immunol. Res. 2025;73:105. doi: 10.1007/s12026-025-09661-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Vargas-Caballero M., Warming H., Walker R., Holmes C., Cruickshank G., Patel B. Vagus Nerve Stimulation as a Potential Therapy in Early Alzheimer’s Disease: A Review. Front. Hum. Neurosci. 2022;16:866434. doi: 10.3389/fnhum.2022.866434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Walter U., Tsiberidou P., Kersten M., Storch A., Löhle M. Atrophy of the Vagus Nerve in Parkinson’s Disease Revealed by High-Resolution Ultrasonography. Front. Neurol. 2018;9:805. doi: 10.3389/fneur.2018.00805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163.Henssen D.J.H.A., Derks B., van Doorn M., Verhoogt N., Van Cappellen van Walsum A.-M., Staats P., Vissers K. Vagus Nerve Stimulation for Primary Headache Disorders: An Anatomical Review to Explain a Clinical Phenomenon. Cephalalgia. 2019;39:1180–1194. doi: 10.1177/0333102419833076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.George M.S., Ward H.E., Ninan P.T., Pollack M., Nahas Z., Anderson B., Kose S., Howland R.H., Goodman W.K., Ballenger J.C. A Pilot Study of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Anxiety Disorders. Brain Stimulat. 2008;1:112–121. doi: 10.1016/j.brs.2008.02.001. [DOI] [PubMed] [Google Scholar]
  • 165.Taylor W.R., Chen J.W., Meltzer H., Gennarelli T.A., Kelbch C., Knowlton S., Richardson J., Lutch M.J., Farin A., Hults K.N., et al. Quantitative Pupillometry, a New Technology: Normative Data and Preliminary Observations in Patients with Acute Head Injury: Technical Note. J. Neurosurg. 2003;98:205–213. doi: 10.3171/jns.2003.98.1.0205. [DOI] [PubMed] [Google Scholar]
  • 166.Rattan Y., Girgla K.K., Mahajan G., Prasher P. Measurement of Dynamic Pupillometry Parameters in Adult Indian Population. Indian. J. Ophthalmol. 2024;72:1611–1617. doi: 10.4103/IJO.IJO_953_23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Wang Y., Zekveld A.A., Naylor G., Ohlenforst B., Jansma E.P., Lorens A., Lunner T., Kramer S.E. Parasympathetic Nervous System Dysfunction, as Identified by Pupil Light Reflex, and Its Possible Connection to Hearing Impairment. PLoS ONE. 2016;11:e0153566. doi: 10.1371/journal.pone.0153566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Szabadi E. Functional Organization of the Sympathetic Pathways Controlling the Pupil: Light-Inhibited and Light-Stimulated Pathways. Front. Neurol. 2018;9:1069. doi: 10.3389/fneur.2018.01069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Karahan M., Demirtaş A.A., Hazar L., Erdem S., Ava S., Dursun M.E., Keklikçi U. Autonomic Dysfunction Detection by an Automatic Pupillometer as a Non-Invasive Test in Patients Recovered from COVID-19. Graefe’s Arch. Clin. Exp. Ophthalmol. 2021;259:2821–2826. doi: 10.1007/s00417-021-05209-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Lohkamp L.-N., Marathe N., Fehlings M.G. Craniocervical Instability in Ehlers–Danlos Syndrome—A Systematic Review of Diagnostic and Surgical Treatment Criteria. Glob. Spine J. 2022;12:1862–1871. doi: 10.1177/21925682211068520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Russek L. Cervical Instability in Hypermobile Patients: When Orthopedic Problems Cause Neurological Issues. [(accessed on 24 February 2026)]. Available online: https://www.jospt.org/doi/10.2519/jospt.blog.20230917.
  • 172.Hackett G.S., Hemwall G.A., Montgomery G.A. Ligament and Tendon Relaxation Treated by Prolotherapy. 5th ed. Gustav A. Hemwall; Oak Park, IL, USA: 1993. [Google Scholar]
  • 173.Hauser R.A., Lackner J.B., Steilen-Matias D., Harris D.K. A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Clin. Med. Insights Arthritis Musculoskelet. Disord. 2016;9:CMAMD.S39160. doi: 10.4137/CMAMD.S39160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Hauser R.A., Matias D., Woznica D., Rawlings B., Woldin B.A. Lumbar Instability as an Etiology of Low Back Pain and Its Treatment by Prolotherapy: A Review. J. Back Musculoskelet. Rehabil. 2022;35:701–712. doi: 10.3233/BMR-210097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175.Centeno C.J., Pastoriza S.M. Past, current and future interventional orthobiologics techniques and how they relate to regenerative rehabilitation: A clinical commentary. Int. J. Sports Phys. Ther. 2020;15:301–325. doi: 10.26603/ijspt20200301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176.Goh S.-L., Jaafar Z., Gan Y.-N., Choong A., Kaur J., Kundakci B., Abdul Karim S., Jaffar M.R., A Hamid M.S. Efficacy of Prolotherapy in Comparison to Other Therapies for Chronic Soft Tissue Injuries: A Systematic Review and Network Meta-Analysis. PLoS ONE. 2021;16:e0252204. doi: 10.1371/journal.pone.0252204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177.Giordano L., Murrell W.D., Maffulli N. Prolotherapy for Chronic Low Back Pain: A Review of Literature. Br. Med. Bull. 2021;4:96–111. doi: 10.1093/bmb/ldab004. [DOI] [PubMed] [Google Scholar]
  • 178.Hauser R.A., Hauser M.A. Dextrose Prolotherapy for Unresolved Neck Pain. Pract. Pain Manag. 2007;7:56–60. [Google Scholar]
  • 179.Hakim A. Hypermobile Ehlers–Danlos Syndrome. In: Adam M.P., Bick S., Mirzaa G.M., Pagon R.A., Wallace S.E., Amemiya A., editors. GeneReviews®. University of Washington; Seattle, WA, USA: 1993. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.


Articles from Journal of Clinical Medicine are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES